Crailar (CRLRF) 10-K 28 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 28, 2013	Mar. 24, 2014	Jun. 29, 2013
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	28-Dec-13	'	'
Trading Symbol	'crlrf	'	'
Entity Registrant Name	'CRAILAR TECHNOLOGIES INC	'	'
Entity Central Index Key	'0001210294	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	50,679,097	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Well Known Seasoned Issuer	'No	'	'
Entity Public Float	'	'	$44,399,388
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 28, 2013	Dec. 31, 2012
Current	'	'
Cash and cash equivalents	$1,193,365	$2,877,210
Receivables	223,105	72,292
Inventory	945,040	2,904,652
Prepaid expenses and deposits	290,872	106,785
Total Current Assets	2,652,382	5,960,939
Deferred Debt Issuance Costs	1,442,023	1,024,294
Property and Equipment, net	17,240,012	13,248,688
Intangible Assets, net	155,545	94,619
Total Assets	21,489,962	20,328,540
Current	'	'
Accounts payable	2,377,901	1,406,418
Accrued liabilities	2,342,153	1,480,624
Unearned revenue	247,655	0
Notes payable	476,614	0
Current portion of loans	634,486	0
Derivative liabilities	0	488,035
Total Current Liabilities	6,078,809	3,375,077
Deferred Income Tax Liability	199,131	0
Loans Payable	551,190	0
Long Term Debt	16,674,686	10,051,262
Total Liabilities	23,503,816	13,426,339
STOCKHOLDERS' EQUITY (DEFICIT)	'	'
Capital Stock Authorized: 100,000,000 common shares without par value Issued and outstanding : 47,806,031 common shares (December 31, 2012 - 44,239,198)	34,889,370	32,616,795
Subscription receivable	0	-64,050
Additional Paid-in Capital	9,934,322	7,061,406
Accumulated Other Comprehensive Income (Loss)	585,301	-459,036
Deficit	-11,485,251	-11,485,251
Deficit accumulated in the development stage	-35,937,596	-20,767,663
Total Stockholders Equity	-2,013,854	6,902,201
Total Liabilities and Stockholders Equity	$21,489,962	$20,328,540

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 28, 2013	Dec. 31, 2012
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, No Par Value	'	'
Common Stock, Shares, Issued	47,806,031	44,239,198
Common Stock, Shares, Outstanding	47,806,031	44,239,198

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended		51 Months Ended
	Dec. 28, 2013	Dec. 31, 2012	Dec. 28, 2013
Revenues	$587,225	$0	$587,225
Cost of sales	'	'	'
Materials and direct production costs	470,115	0	470,115
Facility commissioning costs	1,896,822	0	1,896,822
Depreciation	680,839	0	680,839
Impairment loss on inventory	4,642,262	0	4,642,262
Total Cost of sales	7,690,038	0	7,690,038
Gross loss	-7,102,813	0	-7,102,813
Expenses	'	'	'
Marketing and promotion	663,438	672,305	1,594,475
Amortization and depreciation	174,555	278,805	560,418
General and administrative	5,681,467	6,608,524	20,936,061
Total Expenses	6,519,459	7,559,634	23,090,953
Loss before other items	-13,622,272	-7,559,634	-30,193,766
Other income (expense):	'	'	'
Research and development	-355,099	-660,229	-2,595,116
Gain on disposal of assets	790	0	790
Interest	-2,058,738	-99,655	-2,455,400
Write off of equipment	-13,368	-593,894	-704,516
Impairment loss on inventory	0	-303,663	-303,663
Fair value adjustment derivative liabilities	452,845	-98,285	-113,011
Bargain purchase	425,909	0	425,909
Other	0	0	1,177
Total Other income (expense)	-1,547,661	-1,755,726	-5,743,830
Net loss	-15,169,933	-9,315,360	-35,937,596
Other comprehensive income (loss)	'	'	'
Exchange differences on translating to presentation currency	1,044,337	-35,685	'
Comprehensive loss	($14,125,596)	($9,351,045)	'
Loss per share (basic and diluted)	($0.34)	($0.22)	'
Weighted average number of common shares outstanding	44,508,011	43,009,226	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended		51 Months Ended
	Dec. 28, 2013	Dec. 31, 2012	Dec. 28, 2013
Cash flows used in operating activities	'	'	'
Net loss	($15,169,933)	($9,315,360)	($35,937,596)
Adjustments to reconcile net loss to net cash from operating activities	'	'	'
Accretion expense	127,525	0	127,525
Amortization and depreciation	855,394	278,805	1,241,257
Amortization of deferred debt issuance costs	346,789	90,220	437,009
Fair value adjustment of derivative liability	-452,845	98,285	113,011
Gain on disposal of assets	-790	0	-790
Rent	151,539	119,836	271,375
Stock-based compensation	2,004,647	2,397,819	8,142,956
Write off of equipment	13,368	593,894	704,516
Impairment of inventory	4,642,262	303,663	4,945,925
Bargain purchase	425,909	0	425,909
Gain on foreign exchange	0	0	-71,990
Changes in working capital assets and liabilities	'	'	'
Decrease (increase) in accounts receivable	-86,763	78,622	-82,108
Increase in inventory	-2,682,650	-2,172,349	-5,890,965
Increase in prepaid expenses	-184,087	-59,538	-220,747
Increase in accounts payable	971,483	1,170,703	2,108,705
Increase in unearned revenue	247,655	0	247,655
Increase in accrued liabilities	709,990	521,769	1,454,498
Increase in loans payable	0	0	56,945
Net cash used in operating activities	-8,080,507	-5,893,631	-21,926,910
Cash flows used in investing activities	'	'	'
Sale of equipment	35,790	0	35,790
Acquisition of property and equipment	-3,907,808	-10,419,945	-17,547,230
Acquisition of intangible assets	-89,306	-30,268	-194,175
Net cash flows used in investing activities	-3,961,324	-10,450,213	-17,705,615
Cash flows from financing activities	'	'	'
Issuance of capital stock and warrants	239,746	3,948,908	22,203,727
Net proceeds from promissory notes	621,009	0	421,009
Proceeds from private placement	1,879,400	0	1,879,400
Proceeds from convertible debenture	8,307,249	10,051,262	18,358,511
Deferred issuance costs	-886,733	-1,083,936	-1,970,669
Related parties payments	0	0	-1,025,960
Net cash flows from financing activities	10,160,671	12,916,234	39,866,018
Effect of exchange rate changes on cash and cash equivalents	197,315	-35,685	-93,575
Increase (decrease) in cash and cash equivalents	-1,683,845	-3,463,295	139,918
Cash and cash equivalents, beginning	2,877,210	6,340,505	1,053,447
Cash and cash equivalents, ending	1,193,365	2,877,210	1,193,365
SUPPLEMENTAL CASH FLOW INFORMATION AND NON-CASH FINANCING AND INVESTING ACTIVITIES:	'	'	'
Cash paid for interest	1,347,905	9,435	0
Cash paid for income taxes	$0	$0	$0

Statement_of_Stockholders_Equi

Statement of Stockholders Equity (USD $)	Common shares [Member]	Additional paid-in capital [Member]	Subscription Receivable [Member]	Accumulated other comprehensive income \ (loss) [Member]	Deficit [Member]	Deficit (Development stage) [Member]	Total
Beginning Balance at Dec. 31, 2009	$9,422,178	$2,011,047	'	($12,840)	($11,485,251)	($1,159,942)	($1,224,808)
Beginning Balance (Shares) at Dec. 31, 2009	33,354,215	'	'	'	'	'	'
Issuance of common stock on January 12, 2010 for exercise of options at $0.80 per share	2,960	'	'	'	'	'	2,960
Issuance of common stock on January 12, 2010 for exercise of options at $0.80 per share (Shares)	3,700	'	'	'	'	'	'
Issuance of common stock on January 27, 2010 for exercise of options at $0.80 per share	2,240	'	'	'	'	'	2,240
Issuance of common stock on January 27, 2010 for exercise of options at $0.80 per share (Shares)	2,800	'	'	'	'	'	'
Issuance of common stock on February 4, 2010 for exercise of options at $0.80 per share	5,040	'	'	'	'	'	5,040
Issuance of common stock on February 4, 2010 for exercise of options at $0.80 per share (Shares)	6,300	'	'	'	'	'	'
Issuance of common stock on February 23, 2010 for exercise of options at $0.80 per share	2,460	'	'	'	'	'	2,460
Issuance of common stock on February 23, 2010 for exercise of options at $0.80 per share (Shares)	3,075	'	'	'	'	'	'
Issuance of common stock on March 5, 2010 for exercise of options at $0.37 per share	9,250	'	'	'	'	'	9,250
Issuance of common stock on March 5, 2010 for exercise of options at $0.37 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on March 11, 2010 for exercise of options at $0.50 per share	5,000	'	'	'	'	'	5,000
Issuance of common stock on March 11, 2010 for exercise of options at $0.50 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on March 15, 2010 for exercise of options at $0.50 per share	5,000	'	'	'	'	'	5,000
Issuance of common stock on March 15, 2010 for exercise of options at $0.50 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share	10,000	'	'	'	'	'	10,000
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (second)	5,000	'	'	'	'	'	5,000
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (second) (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (third)	5,000	'	'	'	'	'	5,000
Issuance of common stock on March 23, 2010 for exercise of options at $0.50 per share (third) (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on March 29, 2010 for exercise of options at $0.80 per share	1,400	'	'	'	'	'	1,400
Issuance of common stock on March 29, 2010 for exercise of options at $0.80 per share (Shares)	1,750	'	'	'	'	'	'
Issuance of common stock on April 13, 2010 for exercise of options at $0.80 per share	20,000	'	'	'	'	'	20,000
Issuance of common stock on April 13, 2010 for exercise of options at $0.80 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on April 29, 2010 for exercise of options at $0.50 per share	24,000	'	'	'	'	'	24,000
Issuance of common stock on April 29, 2010 for exercise of options at $0.50 per share (Shares)	48,000	'	'	'	'	'	'
Issuance of common stock on May 5, 2010 for exercise of options at $0.50 per share	12,000	'	'	'	'	'	12,000
Issuance of common stock on May 5, 2010 for exercise of options at $0.50 per share (Shares)	24,000	'	'	'	'	'	'
Issuance of common stock on May 7, 2010 for exercise of options at $0.50 per share	34,000	'	'	'	'	'	34,000
Issuance of common stock on May 7, 2010 for exercise of options at $0.50 per share (Shares)	68,000	'	'	'	'	'	'
Issuance of common stock on May 13, 2010 for exercise of options at $0.50 per share	25,000	'	'	'	'	'	25,000
Issuance of common stock on May 13, 2010 for exercise of options at $0.50 per share (Shares)	50,000	'	'	'	'	'	'
Issuance of common stock on May 14, 2010 for exercise of options at $0.50 per share	60,000	'	'	'	'	'	60,000
Issuance of common stock on May 14, 2010 for exercise of options at $0.50 per share (Shares)	120,000	'	'	'	'	'	'
Issuance of common stock on May 19, 2010 for cash - $1.00, net of share issue costs	1,362,587	'	'	'	'	'	1,362,587
Issuance of common stock on May 19, 2010 for cash - $1.00, net of share issue costs (Shares)	1,424,739	'	'	'	'	'	'
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share	20,000	'	'	'	'	'	20,000
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share (second)	10,000	'	'	'	'	'	10,000
Issuance of common stock on June 15, 2010 for exercise of options at $0.80 per share (second) (Shares)	12,500	'	'	'	'	'	'
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share	13,649	'	'	'	'	'	13,649
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share (Shares)	17,061	'	'	'	'	'	'
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share (second)	13,650	'	'	'	'	'	13,650
Issuance of common stock on July 19, 2010 for exercise of options at $0.80 per share (second) (Shares)	17,062	'	'	'	'	'	'
Issuance of common stock on August 4, 2010 for exercise of options at $0.80 per share	20,000	'	'	'	'	'	20,000
Issuance of common stock on August 4, 2010 for exercise of options at $0.80 per share (Shares)	25,000	'	'	'	'	'	'
Transfer addition paid-in capital for options exercised in the year	171,289	-171,289	'	'	'	'	'
Set up derivative liabilities for warrants granted in the year	-482,960	'	'	'	'	'	-482,960
Stock-based compensation	'	930,644	'	'	'	'	930,644
Foreign currency translation	'	'	'	-112,314	'	'	-112,314
Net loss	'	'	'	'	'	-3,293,439	-3,293,439
Ending Balance at Dec. 31, 2010	10,778,742	2,770,402	'	-125,154	-11,485,251	-4,453,381	-2,514,642
Ending Balance (Shares) at Dec. 31, 2010	35,313,202	'	'	'	'	'	'
Issuance of common stock on January 11, 2011 for exercise of options at US$0.87per share	8,700	'	'	'	'	'	8,700
Issuance of common stock on January 11, 2011 for exercise of options at US$0.87per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on January 18, 2011 for exercise of options at US$1.15 per share	69,000	'	'	'	'	'	69,000
Issuance of common stock on January 18, 2011 for exercise of options at US$1.15 per share (Shares)	60,000	'	'	'	'	'	'
Issuance of common stock on January 27, 2011 for exercise of options at US$1.15 per share	12,420	'	'	'	'	'	12,420
Issuance of common stock on January 27, 2011 for exercise of options at US$1.15 per share (Shares)	10,800	'	'	'	'	'	'
Issuance of common stock on January 27, 2011 for exercise of options at US$0.87 per share	1,544	'	'	'	'	'	1,544
Issuance of common stock on January 27, 2011 for exercise of options at US$0.87 per share (Shares)	1,775	'	'	'	'	'	'
Issuance of common stock on January 31, 2011 for exercise of options at US$1.15 per share	11,500	'	'	'	'	'	11,500
Issuance of common stock on January 31, 2011 for exercise of options at US$1.15 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share	11,500	'	'	'	'	'	11,500
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share (second)	2,875	'	'	'	'	'	2,875
Issuance of common stock on February 1, 2011 for exercise of options at US$1.15 per share (second) (Shares)	2,500	'	'	'	'	'	'
Issuance of common stock on February 1, 2011 for exercise of options at US$0.87 per share	2,175	'	'	'	'	'	2,175
Issuance of common stock on February 1, 2011 for exercise of options at US$0.87 per share (Shares)	2,500	'	'	'	'	'	'
Issuance of common stock on February 10, 2011 for exercise of options at US$0.87 per share	870	'	'	'	'	'	870
Issuance of common stock on February 10, 2011 for exercise of options at US$0.87 per share (Shares)	1,000	'	'	'	'	'	'
Issuance of common stock on February 17, 2011 for exercise of options at US$1.12 per share	28,000	'	'	'	'	'	28,000
Issuance of common stock on February 17, 2011 for exercise of options at US$1.12 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on February 24, 2011 for exercise of warrants at US$1.25 per share	62,500	'	'	'	'	'	62,500
Issuance of common stock on February 24, 2011 for exercise of warrants at US$1.25 per share (Shares)	50,000	'	'	'	'	'	'
Issuance of common stock on February 25, 2011 for exercise of options at US$0.87 per share	5,003	'	'	'	'	'	5,003
Issuance of common stock on February 25, 2011 for exercise of options at US$0.87 per share (Shares)	5,750	'	'	'	'	'	'
Issuance of common stock on March 8, 2011 for exercise of options at US$0.87 per share	4,094	'	'	'	'	'	4,094
Issuance of common stock on March 8, 2011 for exercise of options at US$0.87 per share (Shares)	4,706	'	'	'	'	'	'
Issuance of common stock on March 10, 2011 for exercise of warrants at US$1.25 per share	31,250	'	'	'	'	'	31,250
Issuance of common stock on March 10, 2011 for exercise of warrants at US$1.25 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on March 16, 2011 for exercise of options at US$0.96 per share	6,000	'	'	'	'	'	6,000
Issuance of common stock on March 16, 2011 for exercise of options at US$0.96 per share (Shares)	6,250	'	'	'	'	'	'
Issuance of common stock on March 22, 2011 for exercise of options at US$1.12 per share	22,400	'	'	'	'	'	22,400
Issuance of common stock on March 22, 2011 for exercise of options at US$1.12 per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on March 25, 2011 for exercise of options at US$0.87 per share	3,480	'	'	'	'	'	3,480
Issuance of common stock on March 25, 2011 for exercise of options at US$0.87 per share (Shares)	4,000	'	'	'	'	'	'
Issuance of common stock on March 28, 2011 for exercise of warrants at CDN$1.20 per share	15,700	'	'	'	'	'	15,700
Issuance of common stock on March 28, 2011 for exercise of warrants at CDN$1.20 per share (Shares)	14,273	'	'	'	'	'	'
Issuance of common stock on March 29, 2011 for exercise of options at US$0.96 per share	307,200	'	'	'	'	'	307,200
Issuance of common stock on March 29, 2011 for exercise of options at US$0.96 per share (Shares)	320,000	'	'	'	'	'	'
Issuance of common stock on March 30, 2011 for exercise of options at US$0.96 per share	28,800	'	'	'	'	'	28,800
Issuance of common stock on March 30, 2011 for exercise of options at US$0.96 per share (Shares)	30,000	'	'	'	'	'	'
Issuance of common stock on April 7, 2011 for exercise of warrants at CDN$1.50 per share	2,760	'	'	'	'	'	2,760
Issuance of common stock on April 7, 2011 for exercise of warrants at CDN$1.50 per share (Shares)	2,000	'	'	'	'	'	'
Issuance of common stock on April 8, 2011 for exercise of options at US$0.87 per share	8,700	'	'	'	'	'	8,700
Issuance of common stock on April 8, 2011 for exercise of options at US$0.87 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on April 8, 2011 for exercise of options at $1.12 per share	44,800	'	'	'	'	'	44,800
Issuance of common stock on April 8, 2011 for exercise of options at $1.12 per share (Shares)	40,000	'	'	'	'	'	'
Issuance of common stock on April 14, 2011 for exercise of options at US$1.12 per share	33,600	'	'	'	'	'	33,600
Issuance of common stock on April 14, 2011 for exercise of options at US$1.12 per share (Shares)	30,000	'	'	'	'	'	'
Issuance of common stock on April 14, 2011 for exercise of options at US$1.02 per share	11,730	'	'	'	'	'	11,730
Issuance of common stock on April 14, 2011 for exercise of options at US$1.02 per share (Shares)	11,500	'	'	'	'	'	'
Issuance of common stock on April 19, 2011 for exercise of options at US$0.87 per share	4,350	'	'	'	'	'	4,350
Issuance of common stock on April 19, 2011 for exercise of options at US$0.87 per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on April 19, 2011 for exercise of warrants at CDN$1.95 per share	9,750	'	'	'	'	'	9,750
Issuance of common stock on April 19, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on April 21, 2011 for exercise of options at US$1.12 per share	40,320	'	'	'	'	'	40,320
Issuance of common stock on April 21, 2011 for exercise of options at US$1.12 per share (Shares)	36,000	'	'	'	'	'	'
Issuance of common stock on April 25, 2011 for exercise of warrants at CDN$1.50 per share	9,849	'	'	'	'	'	9,849
Issuance of common stock on April 25, 2011 for exercise of warrants at CDN$1.50 per share (Shares)	7,137	'	'	'	'	'	'
Issuance of common stock on April 25, 2011 for exercise of warrants at US$1.25 per share	31,250	'	'	'	'	'	31,250
Issuance of common stock on April 25, 2011 for exercise of warrants at US$1.25 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on April 28, 2011 for exercise of warrants at CDN$1.95 per share	195,000	'	'	'	'	'	195,000
Issuance of common stock on April 28, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	100,000	'	'	'	'	'	'
Issuance of common stock on April 28, 2011 for exercise of options at US$1.12 per share	56,000	'	'	'	'	'	56,000
Issuance of common stock on April 28, 2011 for exercise of options at US$1.12 per share (Shares)	50,000	'	'	'	'	'	'
Issuance of common stock on May 2, 2011 for exercise of options at US$1.12 per share	22,400	'	'	'	'	'	22,400
Issuance of common stock on May 2, 2011 for exercise of options at US$1.12 per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on May 2, 2011 for exercise of warrants at CDN$1.95 per share	63,484	'	'	'	'	'	63,484
Issuance of common stock on May 2, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	32,556	'	'	'	'	'	'
Issuance of common stock on May 4, 2011 for exercise of warrants at CDN$1.95 per share	36,480	'	'	'	'	'	36,480
Issuance of common stock on May 4, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	18,708	'	'	'	'	'	'
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share	3,750	'	'	'	'	'	3,750
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share (Shares)	3,000	'	'	'	'	'	'
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share (second)	62,500	'	'	'	'	'	62,500
Issuance of common stock on May 4, 2011 for exercise of warrants at US$1.25 per share (second) (Shares)	50,000	'	'	'	'	'	'
Issuance of common stock on May 5, 2011 for exercise of warrants at CDN$1.95 per share	16,251	'	'	'	'	'	16,251
Issuance of common stock on May 5, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	8,334	'	'	'	'	'	'
Issuance of common stock on May 5, 2011 for exercise of options at US$1.12 per share	1,120	'	'	'	'	'	1,120
Issuance of common stock on May 5, 2011 for exercise of options at US$1.12 per share (Shares)	1,000	'	'	'	'	'	'
Issuance of common stock on May 9, 2011 for exercise of warrants at US$1.25 per share	36,080	'	'	'	'	'	36,080
Issuance of common stock on May 9, 2011 for exercise of warrants at US$1.25 per share (Shares)	28,864	'	'	'	'	'	'
Issuance of common stock on May 10, 2011 for exercise of warrants at CDN$1.95 per share	9,750	'	'	'	'	'	9,750
Issuance of common stock on May 10, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.50 per share	2,760	'	'	'	'	'	2,760
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.50 per share (Shares)	2,000	'	'	'	'	'	'
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.95 per share	137,656	'	'	'	'	'	137,656
Issuance of common stock on May 12, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	70,593	'	'	'	'	'	'
Issuance of common stock on May 17, 2011 for exercise of options at US$1.12 per share	1,680	'	'	'	'	'	1,680
Issuance of common stock on May 17, 2011 for exercise of options at US$1.12 per share (Shares)	1,500	'	'	'	'	'	'
Issuance of common stock on May 17, 2011 for exercise of warrants at CDN$1.95 per share	10,834	'	'	'	'	'	10,834
Issuance of common stock on May 17, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	5,556	'	'	'	'	'	'
Issuance of common stock on May 19, 2011 for exercise of warrants at CDN$1.95 per share	3,611	'	'	'	'	'	3,611
Issuance of common stock on May 19, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	1,852	'	'	'	'	'	'
Issuance of common stock on May 19, 2011 for exercise of options at US$1.12 per share	1,344	'	'	'	'	'	1,344
Issuance of common stock on May 19, 2011 for exercise of options at US$1.12 per share (Shares)	1,200	'	'	'	'	'	'
Issuance of common stock on May 24, 2011 for exercise of warrants at CDN$1.95 per share	39,000	'	'	'	'	'	39,000
Issuance of common stock on May 24, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN$1.20 per share	38,456	'	'	'	'	'	38,456
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN$1.20 per share (Shares)	34,960	'	'	'	'	'	'
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN1.50 per share	24,123	'	'	'	'	'	24,123
Issuance of common stock on May 26, 2011 for exercise of warrants at CDN1.50 per share (Shares)	17,480	'	'	'	'	'	'
Issuance of common stock on June 1 , 2011 for exercise of warrants at CDN1.95 per share	223,575	'	'	'	'	'	223,575
Issuance of common stock on June 1 , 2011 for exercise of warrants at CDN1.95 per share (Shares)	114,654	'	'	'	'	'	'
Issuance of common stock on June 9, 2011 for exercise of options at US$1.02 per share	9,180	'	'	'	'	'	9,180
Issuance of common stock on June 9, 2011 for exercise of options at US$1.02 per share (Shares)	9,000	'	'	'	'	'	'
Issuance of common stock on June 10, 2011 for exercise of warrants at CDN1.95 per share	79,445	'	'	'	'	'	79,445
Issuance of common stock on June 10, 2011 for exercise of warrants at CDN1.95 per share (Shares)	40,741	'	'	'	'	'	'
Issuance of common stock on June 13, 2011 for exercise of warrants at CDN1.95 per share	59,588	'	'	'	'	'	59,588
Issuance of common stock on June 13, 2011 for exercise of warrants at CDN1.95 per share (Shares)	30,558	'	'	'	'	'	'
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN1.95 per share	52,182	'	'	'	'	'	52,182
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN1.95 per share (Shares)	26,760	'	'	'	'	'	'
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN$1.50 per share	6,900	'	'	'	'	'	6,900
Issuance of common stock on June 16, 2011 for exercise of warrants at CDN$1.50 per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.50 per share	8,050	'	'	'	'	'	8,050
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.50 per share (Shares)	5,834	'	'	'	'	'	'
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.95 per share	32,861	'	'	'	'	'	32,861
Issuance of common stock on June 23, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	16,852	'	'	'	'	'	'
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share	227,529	'	'	'	'	'	227,529
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	116,680	'	'	'	'	'	'
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share (second)	110,573	'	'	'	'	'	110,573
Issuance of common stock on June 28, 2011 for exercise of warrants at CDN$1.95 per share (second) (Shares)	56,704	'	'	'	'	'	'
Issuance of common stock on July 4, 2011 for exercise of warrants at CDN$1.95 per share	113,442	'	'	'	'	'	113,442
Issuance of common stock on July 4, 2011 for exercise of warrants at CDN$1.95 per share (Shares)	58,175	'	'	'	'	'	'
Issuance of common stock on July 5, 2011 for exercise of options at US$1.12 per share	7,280	'	'	'	'	'	7,280
Issuance of common stock on July 5, 2011 for exercise of options at US$1.12 per share (Shares)	6,500	'	'	'	'	'	'
Issuance of common stock on July 5, 2011 for exercise of options at US$1.02 per share	10,200	'	'	'	'	'	10,200
Issuance of common stock on July 5, 2011 for exercise of options at US$1.02 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on July 8, 2011 for cash $3.45 net of share issuance costs	11,617,021	562,634	'	'	'	'	12,179,655
Issuance of common stock on July 8, 2011 for cash $3.45 net of share issuance costs (Shares)	3,800,000	'	'	'	'	'	'
Issuance of common stock on July 20, 2011 for exercise of warrants at CDN$3.45 per unit , net of commission	729,622	18,386	'	'	'	'	748,008
Issuance of common stock on July 20, 2011 for exercise of warrants at CDN$3.45 per unit , net of commission (Shares)	212,500	'	'	'	'	'	'
Issuance of common stock on July 25, 2011 for exercise of options at US$1.12 per share	1,680	'	'	'	'	'	1,680
Issuance of common stock on July 25, 2011 for exercise of options at US$1.12 per share (Shares)	1,500	'	'	'	'	'	'
Issuance of common stock on Sep 7, 2011 for exercise of options at US$1.12 per share	2,800	'	'	'	'	'	2,800
Issuance of common stock on Sep 7, 2011 for exercise of options at US$1.12 per share (Shares)	2,500	'	'	'	'	'	'
Issuance of common stock on Oct 14, 2011 for exercise of options at US$1.45 per share	725,000	'	'	'	'	'	725,000
Issuance of common stock on Oct 14, 2011 for exercise of options at US$1.45 per share (Shares)	500,000	'	'	'	'	'	'
Issuance of common stock on Oct 18, 2011 for exercise of options at US$0.87 per share	17,400	'	'	'	'	'	17,400
Issuance of common stock on Oct 18, 2011 for exercise of options at US$0.87 per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on Nov 2, 2011 for exercise of options at US$1.02 per share	2,040	'	'	'	'	'	2,040
Issuance of common stock on Nov 2, 2011 for exercise of options at US$1.02 per share (Shares)	2,000	'	'	'	'	'	'
Issuance of common stock on Nov 14, 2011 for exercise of options at US$1.12 per share	4,200	'	'	'	'	'	4,200
Issuance of common stock on Nov 14, 2011 for exercise of options at US$1.12 per share (Shares)	3,750	'	'	'	'	'	'
Issuance of common stock on Nov 14, 2011 for exercise of options at US$0.87 per share	5,437	'	'	'	'	'	5,437
Issuance of common stock on Nov 14, 2011 for exercise of options at US$0.87 per share (Shares)	6,250	'	'	'	'	'	'
Issuance of common stock on Nov 17, 2011 for exercise of options at US$1.12 per share	2,240	'	'	'	'	'	2,240
Issuance of common stock on Nov 17, 2011 for exercise of options at US$1.12 per share (Shares)	2,000	'	'	'	'	'	'
Issuance of common stock on Nov 25, 2011 for exercise of options at US$0.95 per share	23,750	'	'	'	'	'	23,750
Issuance of common stock on Nov 25, 2011 for exercise of options at US$0.95 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on Dec 5, 2011 for exercise of options at US$0.87 per share	8,700	'	'	'	'	'	8,700
Issuance of common stock on Dec 5, 2011 for exercise of options at US$0.87 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on Dec 15, 2011 for exercise of options at US$0.87 per share	6,525	'	'	'	'	'	6,525
Issuance of common stock on Dec 15, 2011 for exercise of options at US$0.87 per share (Shares)	7,500	'	'	'	'	'	'
Issuance of common stock on Dec 19, 2011 for exercise of options at US$1.12 per share	1,568	'	'	'	'	'	1,568
Issuance of common stock on Dec 19, 2011 for exercise of options at US$1.12 per share (Shares)	1,400	'	'	'	'	'	'
Transfer addition paid-in capital for options exercised in the year	770,452	-770,452	'	'	'	'	'
Transfer derivative liability for warrants exercised in the year	153,063	'	'	'	'	'	153,063
Proceeds from issue of warrants	'	32,798	'	'	'	'	32,798
Stock-based compensation	'	2,561,066	'	'	'	'	2,561,066
Foreign currency translation	'	'	'	-298,197	'	'	-298,197
Net loss	'	'	'	'	'	-6,998,922	-6,998,922
Ending Balance at Dec. 31, 2011	27,428,844	5,174,834	'	-423,351	-11,485,251	-11,452,303	9,242,773
Ending Balance (Shares) at Dec. 31, 2011	41,701,604	'	'	'	'	'	'
Issuance of common stock on January 16, 2012 for exercise of options at US$1.12per share	67,200	'	'	'	'	'	67,200
Issuance of common stock on January 16, 2012 for exercise of options at US$1.12per share (Shares)	60,000	'	'	'	'	'	'
Issuance of common stock on January 23, 2012 for exercise of options at US$1.12per share	220,528	'	'	'	'	'	220,528
Issuance of common stock on January 23, 2012 for exercise of options at US$1.12per share (Shares)	196,900	'	'	'	'	'	'
Issuance of common stock on January 24, 2012 for exercise of options at US$0.87per share	17,400	'	'	'	'	'	17,400
Issuance of common stock on January 24, 2012 for exercise of options at US$0.87per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on February 7, 2012 for exercise of options at US$0.87per share	957	'	'	'	'	'	957
Issuance of common stock on February 7, 2012 for exercise of options at US$0.87per share (Shares)	1,100	'	'	'	'	'	'
Issuance of common stock on February 16, 2012 for exercise of options at CDN$1.05per share	2,205	'	'	'	'	'	2,205
Issuance of common stock on February 16, 2012 for exercise of options at CDN$1.05per share (Shares)	2,100	'	'	'	'	'	'
Issuance of common stock on February 20, 2012 for exercise of options at US$0.87per share	8,700	'	'	'	'	'	8,700
Issuance of common stock on February 20, 2012 for exercise of options at US$0.87per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share	101,000	'	'	'	'	'	101,000
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share (Shares)	100,000	'	'	'	'	'	'
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share (second)	8,700	'	'	'	'	'	8,700
Issuance of common stock on February 24, 2012 for exercise of options at US$0.87per share (second) (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on February 28, 2012 for exercise of options at US$0.87per share	4,350	'	'	'	'	'	4,350
Issuance of common stock on February 28, 2012 for exercise of options at US$0.87per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on March 2, 2012 for exercise of warrants at CDN$1.50per share	37,500	'	'	'	'	'	37,500
Issuance of common stock on March 2, 2012 for exercise of warrants at CDN$1.50per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on March 2, 2012 for exercise of options at US$0.95per share	23,750	'	'	'	'	'	23,750
Issuance of common stock on March 2, 2012 for exercise of options at US$0.95per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on March 6, 2012 for exercise of options at US$0.87per share	4,350	'	'	'	'	'	4,350
Issuance of common stock on March 6, 2012 for exercise of options at US$0.87per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on March 8, 2012 for exercise of options at CDN$1.05per share	630	'	'	'	'	'	630
Issuance of common stock on March 8, 2012 for exercise of options at CDN$1.05per share (Shares)	600	'	'	'	'	'	'
Issuance of common stock on March 15, 2012 for exercise of warrants at CDN$1.25per share	291,600	'	'	'	'	'	291,600
Issuance of common stock on March 15, 2012 for exercise of warrants at CDN$1.25per share (Shares)	250,000	'	'	'	'	'	'
Issuance of common stock on March 15, 2012 for exercise of options at CDN$1.05per share	5,775	'	'	'	'	'	5,775
Issuance of common stock on March 15, 2012 for exercise of options at CDN$1.05per share (Shares)	5,500	'	'	'	'	'	'
Issuance of common stock on March 15, 2012 for exercise of options at CDN$0.87per share	4,350	'	'	'	'	'	4,350
Issuance of common stock on March 15, 2012 for exercise of options at CDN$0.87per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on March 23, 2012 for exercise of options at CDN$0.87per share	4,350	'	'	'	'	'	4,350
Issuance of common stock on March 23, 2012 for exercise of options at CDN$0.87per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on March 29, 2012 for exercise of warrants at CDN$1.50 per share	22,500	'	'	'	'	'	22,500
Issuance of common stock on March 29, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	15,000	'	'	'	'	'	'
Issuance of common stock on April 3, 2012 for exercise of options at US$0.96per share	42,000	'	'	'	'	'	42,000
Issuance of common stock on April 3, 2012 for exercise of options at US$0.96per share (Shares)	43,750	'	'	'	'	'	'
Issuance of common stock on April 3, 2012 for exercise of options at CDN$2.74per share	40,770	'	'	'	'	'	40,770
Issuance of common stock on April 3, 2012 for exercise of options at CDN$2.74per share (Shares)	14,585	'	'	'	'	'	'
Issuance of common stock on April 3, 2012 for exercise of warrants at CDN$1.50 per share	30,000	'	'	'	'	'	30,000
Issuance of common stock on April 3, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on April 4, 2012 for exercise of options at US$0.87per share	8,695	'	'	'	'	'	8,695
Issuance of common stock on April 4, 2012 for exercise of options at US$0.87per share (Shares)	9,994	'	'	'	'	'	'
Issuance of common stock on April 12, 2012 for exercise of options at CDN$1.05per share	1,050	'	'	'	'	'	1,050
Issuance of common stock on April 12, 2012 for exercise of options at CDN$1.05per share (Shares)	1,000	'	'	'	'	'	'
Issuance of common stock on April 13, 2012 for exercise of warrants at CDN$1.25 per share	3,750	'	'	'	'	'	3,750
Issuance of common stock on April 13, 2012 for exercise of warrants at CDN$1.25 per share (Shares)	3,000	'	'	'	'	'	'
Issuance of common stock on May 15, 2012 for exercise of warrants at CDN$1.50 per share	7,500	'	'	'	'	'	7,500
Issuance of common stock on May 15, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.50 per share	15,000	'	'	'	'	'	15,000
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.25 per share	2,500	'	'	'	'	'	2,500
Issuance of common stock on May 22, 2012 for exercise of warrants at CDN$1.25 per share (Shares)	2,000	'	'	'	'	'	'
Issuance of common stock on June 4, 2012 for exercise of warrants at CDN$1.50 per share	2,250	'	'	'	'	'	2,250
Issuance of common stock on June 4, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	1,500	'	'	'	'	'	'
Issuance of common stock on June 11, 2012 for exercise of options at CDN$0.87per share	1,088	'	'	'	'	'	1,088
Issuance of common stock on June 11, 2012 for exercise of options at CDN$0.87per share (Shares)	1,250	'	'	'	'	'	'
Issuance of common stock on June 11, 2012 for exercise of options at US$1.03per share	10,300	'	'	'	'	'	10,300
Issuance of common stock on June 11, 2012 for exercise of options at US$1.03per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on July 4, 2012 for exercise of options at US$1.17per share	8,775	'	'	'	'	'	8,775
Issuance of common stock on July 4, 2012 for exercise of options at US$1.17per share (Shares)	7,500	'	'	'	'	'	'
Issuance of common stock on July 9, 2012 for exercise of options at US$1.01per share	63,125	'	'	'	'	'	63,125
Issuance of common stock on July 9, 2012 for exercise of options at US$1.01per share (Shares)	62,500	'	'	'	'	'	'
Issuance of common stock on July 13, 2012 for exercise of options at US$1.01per share	63,125	'	'	'	'	'	63,125
Issuance of common stock on July 13, 2012 for exercise of options at US$1.01per share (Shares)	62,500	'	'	'	'	'	'
Issuance of common stock on July 19, 2012 for exercise of warrants at CDN$1.50 per share	62,501	'	'	'	'	'	62,501
Issuance of common stock on July 19, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	41,667	'	'	'	'	'	'
Issuance of common stock on August 30, 2012 for exercise of warrants at CDN$1.50 per share	3,750	'	'	'	'	'	3,750
Issuance of common stock on August 30, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	2,500	'	'	'	'	'	'
Issuance of common stock on August 30, 2012 for exercise of options at CDN$0.87per share	8,222	'	'	'	'	'	8,222
Issuance of common stock on August 30, 2012 for exercise of options at CDN$0.87per share (Shares)	9,450	'	'	'	'	'	'
Issuance of common stock on September 6, 2012 for exercise of options at US$0.96per share	19,200	'	'	'	'	'	19,200
Issuance of common stock on September 6, 2012 for exercise of options at US$0.96per share (Shares)	20,000	'	'	'	'	'	'
Issuance of common stock on September 6, 2012 for exercise of options at US$1.17per share	11,700	'	'	'	'	'	11,700
Issuance of common stock on September 6, 2012 for exercise of options at US$1.17per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on September 12, 2012 for exercise of warrants at CDN$1.50 per share	3,750	'	'	'	'	'	3,750
Issuance of common stock on September 12, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	2,500	'	'	'	'	'	'
Issuance of common stock on September 12, 2012 for exercise of warrants at US$1.38 per share	2,760	'	'	'	'	'	2,760
Issuance of common stock on September 12, 2012 for exercise of warrants at US$1.38 per share (Shares)	2,000	'	'	'	'	'	'
Issuance of common stock on September 13, 2012 for cash - USD$2.21, net of share issue costs	889,383	'	'	'	'	'	889,383
Issuance of common stock on September 13, 2012 for cash - USD$2.21, net of share issue costs (Shares)	418,429	'	'	'	'	'	'
Issuance of common stock on September 17, 2012 for exercise of warrants at US$1.38 per share	20,700	'	'	'	'	'	20,700
Issuance of common stock on September 17, 2012 for exercise of warrants at US$1.38 per share (Shares)	15,000	'	'	'	'	'	'
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.30 per share	28,392	'	'	'	'	'	28,392
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.30 per share (Shares)	21,840	'	'	'	'	'	'
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.50 per share	3,126	'	'	'	'	'	3,126
Issuance of common stock on September 17, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	2,084	'	'	'	'	'	'
Issuance of common stock on September 19, 2012 for exercise of warrants at US$1.38 per share	207,000	'	'	'	'	'	207,000
Issuance of common stock on September 19, 2012 for exercise of warrants at US$1.38 per share (Shares)	150,000	'	'	'	'	'	'
Issuance of common stock on September 21, 2012 for exercise of warrants at US$1.38 per share	69,000	'	'	'	'	'	69,000
Issuance of common stock on September 21, 2012 for exercise of warrants at US$1.38 per share (Shares)	50,000	'	'	'	'	'	'
Issuance of common stock on September 21, 2012 for exercise of warrants at CDN$1.50 per share	44,250	'	'	'	'	'	44,250
Issuance of common stock on September 21, 2012 for exercise of warrants at CDN$1.50 per share (Shares)	29,500	'	'	'	'	'	'
Issuance of common stock on September 24, 2012 for cash - USD$2.21, net of share issue costs	958,100	'	'	'	'	'	958,100
Issuance of common stock on September 24, 2012 for cash - USD$2.21, net of share issue costs (Shares)	450,758	'	'	'	'	'	'
Issuance of common stock on October 10, 2012 for cash - USD$2.21, net of share issue costs	438,877	'	-64,050	'	'	'	374,827
Issuance of common stock on October 10, 2012 for cash - USD$2.21, net of share issue costs (Shares)	198,587	'	'	'	'	'	'
Issuance of common stock on October 17, 2012 for exercise of options at US$1.17per share	8,775	'	'	'	'	'	8,775
Issuance of common stock on October 17, 2012 for exercise of options at US$1.17per share (Shares)	7,500	'	'	'	'	'	'
Issuance of common stock on November 2, 2012 for exercise of options at US$0.96per share	96,000	'	'	'	'	'	96,000
Issuance of common stock on November 2, 2012 for exercise of options at US$0.96per share (Shares)	100,000	'	'	'	'	'	'
Issuance of common stock on November 20, 2012 for exercise of options at US$1.17per share	11,700	'	'	'	'	'	11,700
Issuance of common stock on November 20, 2012 for exercise of options at US$1.17per share (Shares)	10,000	'	'	'	'	'	'
Transfer addition paid-in capital for options exercised in the year	511,247	-511,247	'	'	'	'	'
Set up derivative liabilities for warrants granted in the year	-280,496	'	'	'	'	'	-280,496
Transfer derivative liability for warrants exercised in the year	873,728	'	'	'	'	'	873,728
Transfer derivative liability for warrants expired in the year	70,514	'	'	'	'	'	70,514
Stock-based compensation	'	2,397,819	'	'	'	'	2,397,819
Foreign currency translation	'	'	'	-35,685	'	'	-35,685
Net loss	'	'	'	'	'	-9,315,360	-9,315,360
Ending Balance at Dec. 31, 2012	32,616,795	7,061,406	-64,050	-459,036	-11,485,251	-20,767,663	6,902,201
Ending Balance (Shares) at Dec. 31, 2012	44,239,198	'	'	'	'	'	'
Issuance of common stock on January 9, 2013 for exercise of options at US $1.17per share	5,850	'	'	'	'	'	5,850
Issuance of common stock on January 9, 2013 for exercise of options at US $1.17per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on January 22, 2013 for exercise of options at US$1.02per share	26,520	'	'	'	'	'	26,520
Issuance of common stock on January 22, 2013 for exercise of options at US$1.02per share (Shares)	26,000	'	'	'	'	'	'
Issuance of common stock on February 5, 2013 for exercise of options at US$1.17per share	5,850	'	'	'	'	'	5,850
Issuance of common stock on February 5, 2013 for exercise of options at US$1.17per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on February 13, 2013 for exercise of options at CAD$0.95 per share	23,750	'	'	'	'	'	23,750
Issuance of common stock on February 13, 2013 for exercise of options at CAD$0.95 per share (Shares)	25,000	'	'	'	'	'	'
Issuance of common stock on March 1, 2013 for exercise of options at CAD $0.96 per share	116,951	'	'	'	'	'	116,951
Issuance of common stock on March 1, 2013 for exercise of options at CAD $0.96 per share (Shares)	120,000	'	'	'	'	'	'
Issuance of common stock on March 8, 2013 for exercise of options at CAD $0.96 per share	9,600	'	'	'	'	'	9,600
Issuance of common stock on March 8, 2013 for exercise of options at CAD $0.96 per share (Shares)	10,000	'	'	'	'	'	'
Issuance of common stock on March 23, 2013 for exercise of options at CAD$0.87 per share	4,350	'	'	'	'	'	4,350
Issuance of common stock on March 23, 2013 for exercise of options at CAD$0.87 per share (Shares)	5,000	'	'	'	'	'	'
Issuance of common stock on April 16, 2013 for exercise of warrants	46,875	'	'	'	'	'	46,875
Issuance of common stock on April 16, 2013 for exercise of warrants (Shares)	37,500	'	'	'	'	'	'
Transfer addition paid-in capital for options exercised in the year	118,239	-118,239	'	'	'	'	'
Debenture warrants	'	754,829	'	'	'	'	754,829
Adjustment to warrant conversion price	'	79,931	'	'	'	'	79,931
Issuance costs of debenture warrants	'	-102,670	'	'	'	'	-102,670
Issuance costs of long term debt and debenture warrants brokers warrants	'	66,278	'	'	'	'	66,278
Transfer from derivative liability warrants exercise	35,190	'	'	'	'	'	35,190
Private placement	1,879,400	'	'	'	'	'	1,879,400
Private placement (Shares)	3,333,333	'	'	'	'	'	'
Stock-based compensation	'	2,004,647	'	'	'	'	2,004,647
Beneficial conversion feature on notes payable	'	188,140	'	'	'	'	188,140
Write off of subscription receivable	'	'	64,050	'	'	'	64,050
Foreign currency translation	'	'	'	1,044,337	'	'	1,044,337
Net loss	'	'	'	'	'	-15,169,933	-15,169,933
Ending Balance at Dec. 28, 2013	$34,889,370	$9,934,322	'	$585,301	($11,485,251)	($35,937,596)	($2,013,854)
Ending Balance (Shares) at Dec. 28, 2013	47,806,031	'	'	'	'	'	'

Nature_of_Operations_and_Basis

Nature of Operations and Basis of Presentation	12 Months Ended
	Dec. 28, 2013
Nature of Operations and Basis of Presentation [Text Block]	'
	1	Nature of Operations and Basis of Presentation
	CRAiLAR Technologies Inc. (the “Company”) was incorporated in the Province of British Columbia, Canada, on October 6, 1998, and is in the business of technological development and of natural sustainable fibers. Effective October 1, 2009, the Company decided to exit the apparel business, which operated under the brand “HTnaturals”. As a result, the Company re-entered the development stage and has focused on its CRAiLAR ® technology.
	The Company’s shares of common stock trade under the symbol “CL”, on the TSX Venture Exchange (“TSX-V”) and under the symbol “CRLRF” on the OTCQB.
	Going concern
	The Company’s consolidated financial statements are prepared using generally accepted accounting principles (“GAAP”) in the United States of America applicable to a going concern, which contemplates the realization of assets and payment of liabilities in the normal course of business. The Company has incurred losses since inception of $47,422,847 and further losses are anticipated in the development of its business. There can be no assurance that the Company will be able to achieve or maintain profitability. Accordingly, these factors raise doubt as to the Company’s ability to continue as a going concern. During 2013 the Company raised $2,119,146 from equity funding for capacity expansion and working capital requirements. The Company plans to raise additional financing in 2014 through equity placements for future capacity expansion. However, there can be no assurance that capital will be available or, if the capital is available, that it will be on terms acceptable to the Company.

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 28, 2013
Significant Accounting Policies [Text Block]	'
	2	Significant Accounting Policies
	a)	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its five wholly-owned subsidiaries as of December 28, 2013: Crailar Inc., a Nevada incorporated company; Hemptown USA, Inc., a Nevada incorporated company; 0697872 B.C. Ltd., a British Columbia incorporated company; Crailar Fiber Technologies Inc., a British Columbia incorporated company, and HTNaturals Apparel Corp, a British Columbia incorporated company. All inter-company transactions and account balances have been eliminated upon consolidation.
	b)	Cash and Cash Equivalents
	Cash equivalents consist of cash on deposit and term deposits with original maturities of one year or less at the time of issuance. As at December 28, 2013, the Company held $15,000 (2012 - $20,000) in cash equivalents.
	c)	Inventory
	The raw flax fiber feedstock, decorticated fiber and Crailar fiber is valued at the lower of cost and market. All direct costs are capitalized to raw flax fiber inventory, decorticated fiber inventory and Crailar fiber.
	Seed inventory was valued at the lower of average cost and market. Cost comprised the cost to purchase seed and/or growing cost plus any related shipping costs.
	Other inventories, which consists of production consumables, are recorded at the lower of cost and replacement cost which approximates net realizable value.
	d)	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Significant areas requiring management’s estimates and assumptions are inventory costing and net realizable value, the expected future use and other impairment considerations of property and equipment, fair value of warrants, options, derivative liabilities, provision for income taxes, depreciation and financial instruments.
	e)	Property and Equipment
	Property and equipment are stated at cost and are depreciated as follows:
		Automobiles	20% declining balance
		Computer equipment	30% declining balance
		Computer software	100% declining balance
		Equipment	30% declining balance
		Furniture and fixtures	20% declining balance
		Production Equipment	30% declining balance
		Leasehold improvements	Term of lease
		Website development	100% declining balance
	Depreciation is claimed at one-half of the regular rate in the year of addition, no depreciation is claimed in the year of disposal.
	f)	Intangible Assets
	Intangible assets are stated at cost and are amortized as follows:
		Trademarks	5 year straight - line
		License Fee	10 year straight - line
		Patent	10 year straight – lin
	g)	Revenue Recognition
	Revenue is recognized when there is persuasive evidence of a sale arrangement, delivery to the customer has occurred, the fee is fixed and determinable, and collectability is considered probable.
	h)	Foreign Currency Translation
	The Company’s functional currency is Canadian dollars. The Company translates its financial statements to U.S. dollars using the following method:
	All assets and liabilities are translated into U.S. dollars at the exchange rate in effect at the year-end. Revenues and expenses are translated throughout the year at the weighted average exchange rate. Exchange gains or losses from such translations are included in accumulated comprehensive income (loss), as a separate component of stockholders’ equity.
	Foreign currency transaction gains and losses are included in the statement of operations and comprehensive loss.
	i)                        Income Taxes
	The Company utilizes the liability method of accounting for deferred income taxes. Under the liability method, deferred income taxes are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates. A valuation allowance is recorded when it is more likely than not that potential the future tax assets will not be realized.
	j)                        Comprehensive Loss
	Comprehensive loss is the change in equity during a period resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Other comprehensive income (loss) comprises items of income and expenses that are not recognized in net loss as required or permitted by GAAP.
	k)                        Stock-based Compensation
	The Company accounts for stock-based payment transactions in which an enterprise receives services in exchange for (a) equity instruments of the enterprise or (b) liabilities that are based on the fair value of the enterprise’s equity instruments or that may be settled by the issuance of such equity instruments. The Company uses the Black-Scholes option-pricing model to establish the fair-value of stock-based awards.
	l)                        Earnings (Loss) Per Share
	Basic and diluted earnings (loss) per share are computed using the weighted average number of shares outstanding during the year. Common stock equivalents from stock options and warrants were excluded from the calculation of net loss per share for the years ended December 28, 2013 and December 31, 2012 as their effect is anti-dilutive.
	m)                        Long-Lived Asset Impairment
	Long-lived assets of the Company are reviewed when changes in circumstances suggest their carrying value has become impaired. Management considers assets to be impaired if the carrying value exceeds the estimated discounted future projected cash flows to result from the use of the asset and its eventual disposition. If impairment is deemed to exist, the assets will be written down to fair value. Fair value is generally determined using a hierarchy of fair value methodologies under GAAP, primarily based on a discounted cash flow analysis.
	n)                        Risk Management
	Currency risk. The Company is exposed to currency risk to the extent that certain inventory and equipment is purchased from Europe. The purchase price for such inventory and equipment is generally in Euros. The Company does not currently hedge its foreign currency exposure, and accordingly, is at risk for foreign currency exchange fluctuations. The Company and its subsidiaries do not have significant transactions or hold significant cash denominated in currencies other than their functional currencies.
	Credit risk. The risk in cash accounts is managed through the use of a major financial institution, which has high credit quality as determined by the rating agencies. As at December 28, 2013, $158,000 is due from a single customer and therefore 61% of receivables are exposed to concentration of credit risk.
	Interest rate risk. Approximately $1,026,000 of the Company’s debt bears interest at fluctuating rates. Consequentially the Company is exposed to interest rate fluctuations. The Company does not currently hedge its exposure to interest rate risk.
	Commodity price risk. Commodity price risk is the risk that the fair value of future cash flows will fluctuate because of changes in the market prices of commodities. The Company is exposed to commodity price risk as it purchases fiber feedstock from the flax producers in Europe. The Company purchases the short fiber waste product called “tow” and the price fluctuates based on supply. The Company has relationships with several short fiber producers and anticipates little issue in obtaining sufficient fiber for its needs. The Company does not currently enter into futures contracts or otherwise hedge its exposure to commodity price risk.
	o)                        Research and Development
	Research and development costs are charged to operations as incurred.
	p)                        Recent Pronouncements There are no recent pronouncements that are applicable to the Company.

Financial_Instruments

Financial Instruments	12 Months Ended
	Dec. 28, 2013
Financial Instruments [Text Block]	'
	3	Financial Instruments
	As at December 28, 2013, the Company concluded that the carrying amount of cash and cash equivalents, receivables, accounts payable, and notes payable to approximate fair value because of the short maturity of these financial instruments. The Company has concluded that the carrying amount of loans payable and long-term debt approximate fair value as they bear interest at market rates. Derivative liabilities are recorded at fair value.

Inventory

Inventory	12 Months Ended
	Dec. 28, 2013
Inventory [Text Block]	'
	4	Inventory
			28-Dec-13		31-Dec-12
	CRAiLAR fiber	$	186,464	$	-
	Decorticated fiber		252,263		51,504
	Flax seed		-		1,172,155
	Raw flax fiber feedstock		369,590		1,680,993
	Other		136,723		-
		$	945,040	$	2,904,652
	The Company wrote down inventory by the following amounts to reduce the book value to net realizable value:
			28-Dec-13		31-Dec-12
	CRAiLAR fiber	$	274,297	$	-
	Decorticated fiber		196,861		-
	Flax seed		1,891,217		303,663
	Raw flax fiber feedstock		2,279,887		-
		$	4,642,262	$	303,663

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 28, 2013
Property and Equipment [Text Block]	'
	5	Property and Equipment
							Net Book Value		Net Book Value
					Accumulated		December 28,		December 31,
			Cost		Depreciation		2013		2012
	Automobiles	$	58,743	$	8,876	$	49,867	$	57,559
	Computer equipment		126,192		69,019		57,180		48,398
	Equipment		754,902		98,556		656,346		359,445
	Equipment held for sale		70,000		-		70,000		105,045
	Furniture and fixtures		62,339		36,918		25,421		29,980
	Leasehold improvements		6,327,333		615,459		5,498,633		4,979,548
	Production equipment		5,095,961		277,681		4,818,280		-
	Production equipment in construction		6,060,849		-		6,060,849		7,606,837
	Website development costs		121,330		117,365		3,436		61,876
		$	18,464,408	$	1,224,396	$	17,240,012	$	13,248,688
	Depreciation of production equipment and leasehold improvements commenced on January 1, 2013 as the Company’s manufacturing facility started production. In August, the company temporarily ceased production and therefore ceased amortization expense on the assets that were not in use.

Intangible_Assets

Intangible Assets	12 Months Ended
	Dec. 28, 2013
Intangible Assets [Text Block]	'
	6	Intangible Assets
					Accumulated		Net Book Value		Net Book Value
			Cost		Amortization		28-Dec-13		31-Dec-12
	Patents	$	158,367	$	72,885	$	85,482	$	77,961
	Trademarks		121,968		93,903		28,065		7,639
	License fee		62,710		20,712		41,998		9,019
		$	343,045	$	187,500	$	155,545	$	94,619

Derivative_liability

Derivative liability	12 Months Ended
	Dec. 28, 2013
Derivative liability [Text Block]	'
	7	Derivative liability
	Derivate liability consists of warrants that were issued in private placements which have exercise prices denominated in a currency other than the Canadian dollar, the Company’s functional currency. This derivative liability is a non-cash liability which the Company is not required to expend any cash to settle. The fair value of the warrants are as follows:
					December 28,		December 31,
			Exercise price		2013		2012
	275,506 warrants expired on May 19, 2013		US$1.25	$	-	$	257,564
	533,887 warrants expiring on Oct 14, 2014		US$3.45		-		230,471
				$	-	$	488,035
	The fair value of these warrants was determined using the Black-Scholes option pricing model, using the following assumptions:
		28-Dec-13	31-Dec-12
	Volatility	60%	57% - 83%
	Dividend yield	-	-
	Risk-free interest rate	0.09%	0.14 – 0.72%
	Expected life	0.62 years	0.38 – 1.18 yrs.
	During the year ended December 28, 2013, 37,500 warrants were exercised and the Company recognized $35,190 of the derivative liability in share capital.

Notes_Payable

Notes Payable	12 Months Ended
	Dec. 28, 2013
Notes Payable [Text Block]	'
	8	Notes Payable
			28-Dec-13
	Principal	$	669,335
	Interest		23,781
	Repayment		(47,885	)
	Beneficial conversion feature		(188,140	)
	Accretion expense		33,495
	Effect of foreign exchange		(13,872	)
		$	476,614
	On October 11, 2013, the Company issued a demand convertible promissory note in favor of Mr. Robert Edmunds, one of its directors, in the principal amount of $467,369 (CAD$500,000). On December 4, 2013,
	the Company issued an additional demand convertible promissory note in favor of Mr. Robert Edmunds, pursuant to a loan from Mr. Robert Edmunds to the Company in the principal amount of $42,255 (CAD$45,000). The promissory notes bear interest on the principle amount at a rate of 20% per annum, is unsecured and payable in full on repayment of the principal amount. The convertible promissory note included 181,666 bonus common shares of the Company, subject to TSX-V approval which was received subsequent to year end (Note 16). At December 28, 2013 the balance outstanding, including accrued interest of $20,896 (CAD$22,667), was $532,576 (CAD$567,267).
	On October 11, 2013, the Company issued a convertible promissory note in favor of Mr. Jason Finnis, one of its directors, in the principal amount of $96,180 (CAD$100,000). The promissory notes bear interest on the principal amount at the rate of 12% per annum, is unsecured and payable in full on repayment of the principle amount. On November 7, 2013, the company repaid Mr. Jason Finnis $48,326 (CAD$50,000) of principal including interest of $441 (CAD$460). At December 28, 2013, the balance outstanding, include accrued interest of $1,210 (CAD$1,290), was $48,132 (CAD$51,290).
	On October 11, 2013, the Company issued a convertible promissory note in favor of Mr. Kenneth Barker, one of its directors, in the principal amount of $50,000. The promissory note bears interest on the principle amount at the rate of 12% per annum, is unsecured and payable in full on repayment of the principal amount. At December 28, 2013, the outstanding balance, including accrued interest of $1,234, was $51,234.
	The promissory notes issued during the year ended December 28, 2013 contain conversion features. Each lender has the right to convert any portion of the outstanding principal and interest payables for units at an exercise price of $0.60 per unit. Each unit is comprised of one common share and one common share purchase warrant of the Company. Each warrant entitles the holder to acquire one common share of the Company at an exercise price of CAD$0.70 per common share for a term of five years. The Company recognized a beneficial conversion feature of $188,140 (CAD$200,000) based on the excess of the conversion price over the commitment date fair value of the stock. The Company incurred an accretion expense of $33,495 (CAD$34,483) during the year reducing the value of the beneficial conversion feature to a balance of $154,645 (CAD$165,517).
	The promissory notes issued during the year ended December 28, 2013 mature on the earliest of December 20, 2014 or at such time the Company completes a public offering of registered securities by way of registration statement on Form S-1 of not less than CAD$3,000,000 in gross proceeds.

Long_term_debt

Long term debt	12 Months Ended
	Dec. 28, 2013
Long term debt [Text Block]	'
	9	Long term debt
	Long term debt:
			28-Dec-13			31-Dec-12
	Balance, beginning	$	10,051,262		$	-
	Convertible debenture issued		8,307,249			10,051,262
	Discount on debentures		(754,829	)		-
	Amendment of debentures – conversion price		(79,931	)		-
	Accretion expense		94,030			-
	Effect of foreign exchange		(943,095	)		-
	Balance, ending	$	16,674,686		$	10,051,262
	Deferred debt issuance costs:
			28-Dec-13			31-Dec-12
	Balance, beginning	$	1,024,294		$	-
	Issuance costs – cash		886,733			1,083,936
	Issuance costs – warrants		66,278			-
	Issuance costs allocated to additional paid in capital		(102,670	)		-
	Amortization of issuance costs		(346,789	)		(59,642	)
	Effect of foreign exchange		(85,823	)		-
		$	1,442,023		$	1,024,294
	On September 20, 2012, the Company completed the offering of $10,051,262 (CAD$10,000,000) convertible debentures (the “2012 Notes”). The 2012 Notes mature on September 20, 2017. The 2012 Notes bear interest at a rate of 10% per year, payable semi-annually on March 31 and September 30, starting March 31, 2013. As at December 28, 2013, accrued interest of $264,143 (2012 - $277,513) (CAD$281,471) (2012 – CAD$277,397) was included in accrued liabilities. During the year ended December 31, 2012, the Company paid a total of $1,083,936 (CAD$1,019,069) in cash issuance costs which have been recorded as deferred debt issuance costs.
	On February 26, 2013, the Company completed an offering of $4,943,643 (CAD$5,000,000) convertible debentures (the “2013 Notes”). The 2013 Notes mature on September 30, 2017. The 2013 Notes bear interest at a rate of 10% per year, payable semi-annually on March 31 and September 30, starting September 30, 2013. As at December 28, 2013, accrued interest of $114,412 (CAD$121,918) was included in accrued liabilities. The Company paid a total of $427,049 (CAD$487,830) in cash issuance costs which have been recorded as deferred debt issuance costs.
	Holders of the 2012 Notes and 2013 Notes have the option to convert at a price of $2.85 (CAD$2.90) per common shares in the capital of the Company at any time prior to the maturity date. The Company may redeem the 2012 Notes and the 2013 Notes after September 30, 2015 provided that the market price at the time of the redemption notice is not less than 125% of the conversion price. The conversion rate is subject to standard anti-dilution provisions.
	The 2012 Notes and 2013 Notes are secured by a Guaranty and Security Agreement signed with the Company’s wholly-owned subsidiary, Crailar Inc. (“CI”), a Nevada incorporated company. CI provides a security interest over its assets, having an aggregate acquisition cost of no less than $5,500,000, as security for its guarantee obligation which shall rank in priority to all other indebtedness of CI.
	The 2012 Notes and 2013 Notes do not contain a beneficial conversion feature, as the fair value of the Company’s common stock on the date of issuance was less than the conversion price. All proceeds from the notes were recorded as a debt instrument.
	On July 26, 2013, the Company closed a convertible debenture offering for gross proceeds of $3,363,606 (CAD$3,535,000) (the “2013A Notes”). The 2013A Notes will mature on July 26, 2016 and will accrue interest at a rate of 10% per year, payable semi-annually in arrears on March 31 and September 30 commencing September 30, 2013. As at December 28, 2013, accrued interest of $80,893 (CAD$86,200) was included in accrued liabilities. At the holder’s option, the debentures may be converted into common shares in the capital of the Company at any time up to the earlier of the maturity date and the business day immediately preceding the date specified by the Company for redemption of the debentures. The conversion price, will be CAD$1.25 per share.
	In addition, the Company issued 800 transferable common share purchase warrants (each, a “Warrant”) for each CAD$1,000 of principal amount, resulting in an aggregate of 2,828,000 Warrants, with each Warrant entitling the holder thereof to purchase one additional Share (each, a “Warrant Share”) at an exercise price of $2.00 per Warrant Share until July 26, 2016. The Company determined the fair value of the warrants to be $974,387 (CAD$1,003,910) using the Black-Scholes Option Pricing Model with the following assumptions: Expected dividend yield – 0; expected stock price volatility – 56%; risk-free interest rate – 0.59%; expected life – 2.83 years.
	The proceeds were allocated to the 2013A Notes and the Warrants based on their relative fair values and accordingly, $2,295,309 (CAD$2,757,300) was allocated to the 2103A Notes and $754,829 (CAD$777,700) was allocated to the Warrants and recorded as a reduction in the 2013A Notes and an increase in additional paid-in capital.
	The Company incurred a total of $440,139 in issuance and commission costs relating to the 2013A Notes. This included $373,861 in cash issuance costs and the fair value of 192,360 broker’s warrants of $66,278. Each broker’s warrant entitles the holder to purchase one common share for $1.25 per share for three years from the date of issuance. The fair value of the brokers’ warrants was calculated using the Black-Scholes Option Pricing Model with the following assumptions: expected dividend yield – 0; expected stock price volatility – 56%; risk-free interest rate – 0.59%; expected life – 2.83 years. The allocation of the 2013A Note issuance costs were based on the relative fair value of the 2013A Notes and the Warrants accordingly, $337,469 was allocated to deferred debt issuance costs and $102,670 was allocated to additional paid-in capital.
	The 2013A Notes included a continuing security interest in the Company’s assets. On December 17, 2013 the Guaranty and Security Agreement was amended to only include certain specific assets held by the Company which had an acquisition cost of $3,922,240. As consideration for the modification, the conversion price of the debentures was amended to $1.25 per warrant. The Company determined the fair value of the additional debt discount to be $79,931 using the Black-Scholes Option Pricing Model with the following assumptions: Expected dividend yield – 0; Expected stock price volatility – 56%; Risk-free interest rate – 0.59%; Expected life – 2.42 years.
	During the year ending December 28, 2013 the Company recorded amortization of the 2013A Notes debt discount in the amount of $94,030 which was included in interest expense.
	During the year ended December 28, 2013, the Company recorded $346,789 (2012: $59,642) in interest expense for the amortization of deferred issuance costs.

Capital_Stock

Capital Stock	12 Months Ended
	Dec. 28, 2013
Capital Stock [Text Block]	'
	10	Common Stock
	During the year ended December 28, 2013, the Company issued shares of common stock as follows:
		a)	The Company closed a private placement with a closing date of December 20, 2013 for 3,333,333 units for aggregate gross proceeds of $1,879,400 (CAD$2,000,000). Each unit is comprised of one common share and one common share purchase warrant of the Company. Each warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of CAD$0.70 per common share for a term of five years. The Company used the residual method to value the warrants and determined the value to be nominal.
		b)	The Company issued a total of 196,000 common shares pursuant to the exercise of employee and consultants’ options between the exercise prices of $0.87 and $1.17 per share for gross proceeds of $192,871. Of this amount, a total of 166,000 options with total proceed of $163,020 were exercised by the directors and officers of the Company.
		c)	The Company issued 37,500 common shares pursuant to the exercise of warrants with an exercise price of $1.25 per share for proceeds of $46,875.
		During the year ended December 31, 2012, the Company issued shares of common stock as follows:
		a)	The Company closed three tranches of a private placement with the last closing on October 10, 2012 for 1,067,774 units for aggregate gross proceeds of $2,359,780. Proceeds of $64,050 were included in subscription receivable as at December 31, 2012. This was subsequently written off during the year ended December 28, 2013. Each unit is comprised of one common share and one half of one common share purchase warrant of the Company. Each warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of $3.45 per common share for a term of two years. The fair value of the warrants was estimated to be $280,496 using the Black Scholes option pricing model, a 2 year term, an expected volatility of 66% to 67% and a risk free interest rate of 0.23% to 25%. The fair value of the warrants was recorded in the derivative liability as the warrants have an exercise price in a currency other than the Company’s functional currency.
		b)	The Company issued 821,299 common shares pursuant to the exercise of employee and consultants’ options between $0.87 and $2.77 per share for proceeds of $868,768, of this a total of 565,635 options for total proceeds of $608,376 were exercised by the directors and officers of the Company.
		c)	The Company issued 648,591 common shares pursuant to the exercise of warrants with an exercise price between $1.20 and $1.38 per share for proceeds of $859,285.
	Warrants
	Stock purchase warrants outstanding at December 28, 2013 are summarized as follows:
				Weighted Average
				Remaining
		Range of Exercise Prices	Number of Warrants	Contractual Life
		$0.70 - $3.45	6,887,580	3.60 years
	A summary of the Company’s stock purchase warrants are as follows:
					Weighted-
					Average
			Shares		Exercise Price
	Warrants outstanding at December 31, 2011		3,294,229		3.57
	Warrants granted during the year		541,167		3.42
	Warrants expired during the year		(29,957	)	1.38
	Warrants exercised during the year		(648,591	)	1.32
	Warrants outstanding at December 31, 2012		3,156,848		4.02
	Warrants granted during the year		6,353,963		0.96
	Warrants expired during the year		(2,585,731	)	4.17
	Warrants exercised during the year		(37,500	)	1.25
	Warrants outstanding at December 28, 2013		6,887,580		1.15

Stock_Options

Stock Options	12 Months Ended
	Dec. 28, 2013
Stock Options [Text Block]	'
	11.               Stock Options
	Amended 2011 Fixed Share Option Plan
	On June 26, 2012, the board amended the Company’s 2011 Fixed Share Option Plan to increase the number of common shares reserved for the issuance under the Company’s 2011 Fixed Share Option Plan from 8,224,240 to 8,512,976 thereunder. On September 9, 2013, the board further amended the Company’s 2011 Fixed Share Option Plan to increase the number of common shares reserved for the issuance under the Company’s 2011 Fixed Share Option Plan from 8,512,976 to 8,894,539 thereunder and to remove the vesting schedule attached as Schedule “B” to the 2011 Fixed Share Option Plan. All other terms of the 2011 Fixed Share Option Plan will remain unchanged.
	The fair value of options issued during the years ended December 28, 2013 and 2012 were determined using the Black-Scholes option pricing model with the following assumptions:
			Year ended			Year ended
			28-Dec-13			31-Dec-12
	Risk-free interest rates		0.75% to 0.90%			0.18% to 0.39%
	Volatility factor		63% to 66%			74% to 75%
	Expected life of options, in years		4.2			4.17
	Weighted average fair value of options granted		$1.15			$1.34
	During the year ended December 28, 2013, the Company granted a total of 285,000 (2012 – 1,849,500) common stock options to directors, officers, employees, eligible consultants, exercisable between $2.24 to $2.30 per share (2012 - $2.23 to $2.31), with a term of five years and an estimated fair value of $328,757 (2012 - $1,973,289).
	During the year ended December 28, 2013, 2,253,762 (2012 – 303,250) options vested. Total expense of $1,889,307 (2012 - $325,724) was recorded as stock-based compensation, $1,582,705 (2012 - $279,914) was charged to salaries and benefits expense and $306,602 (2012 - $45,810) was charged to consulting and contract labor expense.
	Original 2011 Fixed Share Option Plan
	In September 2011, the Company’s Board of Directors approved the 2011 Fixed Share Option Plan (the “2011 Plan”), a non-shareholder approved plan for grants of stock options to directors, officers, employees, eligible consultants of the Company and any related company. Based on the terms of the individual option grants, options granted under the 2011 Plan generally expire three to ten years after the grant date and become exercisable over a period of one year, based on continued employment, either with monthly vesting or upon achievement of predetermined deliverables. The 2011 Plan permits the granting of incentive stock options and nonqualified stock options up to an aggregate at any point in time of 8,224,240 shares.
	The fair value of options issued during the year ended December 31, 2012 was determined using the Black-Scholes option pricing model with the following assumptions:
			Year ended
			31-Dec-12
	Risk-free interest rates		0.78% to 0.92%
	Volatility factor		88% to 89%
	Expected life of options, in years		5
	Weighted average fair value of options granted		$2.14
	During the year ended December 28, 2013, the Company granted a total of nil (2012 - 125,000) common stock options to directors, officers, employees, eligible consultants, exercisable at $1.31 to $2.09 per share, with a term of five years with an estimated fair value of $nil (2012 - $210,136).
	During the year ended December 28, 2013, 25,000 (2012 – 85,423) options vested. Total expense of $38,273 (2012 – $210,275) was recorded as stock-based compensation and $38,273 (2012 – $210,275) was charged to salaries and benefits expense.
	2010 Fixed Share Option Plan
	In September 2010, the Company’s Board of Directors approved the 2010 Fixed Share Option Plan (the “2010 Plan”), a non-shareholder approved plan for grants of stock options to directors, officers, employees, eligible consultants of the Company and any related company. Based on the terms of the individual option grants, options granted under the 2010 Plan generally expire three to ten years after the grant date and become exercisable over a period of one year, based on continued employment, either with monthly vesting or upon achievement of predetermined deliverables. The 2010 Plan permits the granting of incentive stock options and nonqualified stock options up to an aggregate at any point in time of 7,057,640 shares.
	The fair value of options issued during the years ended December 31, 2012 were determined using the Black-Scholes option pricing model with the following assumptions:
			Year ended
			31-Dec-12
	Risk-free interest rates		0.90% to 0.1.56%
	Volatility factor		68% to 91%
	Expected life of options, in years		5
	Weighted average fair value of options granted		$1.66
	During the year ended December 28, 2013, 500,000 (2012 - 862,356) options vested. Total expense of $77,067 (2012 - $1,861,820) was recorded as stock-based compensation, $77,067 (2012 - $1,602,219) was included in salaries and benefits expense and $nil (2012 - $259,601) was included in consulting and labour expense.
	A summary of the Company’s stock options are as follows:
						Weighted-Average
			Shares			Exercise Price
	Options outstanding, December 31, 2011		5,281,945		$	1.48
	Options exercised during the year		(821,229	)		1.06
	Options granted during the year		1,974,500			2.25
	Options cancelled during the year		(19,173	)		1.93
	Options outstanding, December 31, 2012		6,416,043			1.77
	Options exercised during the year		(196,000	)		0.98
	Options granted during the year		285,000			2.25
	Options cancelled/expired during the year		(36,244	)		2.09
	Options outstanding, December 28, 2013		6,468,799			1.81
	December 28, 2013
	Options Outstanding				Options Exercisable
			Weighted
			Average	Weighted		Weighted
	Range of		Remaining	Average		Average
	Exercise	Number	Contractual	Exercise	Number	Exercise
	Prices	Outstanding	Life (yr.)	Price	Exercisable	Price
	$0.87 - $3.05	6,468,799	2.46	$1.81	6,301,720	$1.81
	December 31, 2012
	Options Outstanding				Options Exercisable
			Weighted
			Average	Weighted		Weighted
	Range of		Remaining	Average		Average
	Exercise	Number	Contractual	Exercise	Number	Exercise
	Prices	Outstanding	Life (yr.)	Price	Exercisable	Price
	$0.87 - $3.05	6,416,043	4.98	$1.77	4,304,990	$1.69

Business_Combination

Business Combination	12 Months Ended
	Dec. 28, 2013
Business Combination [Text Block]	'
	12	Business Combination
	On December 1, 2013 the Company acquired the assets of Schrurs NV, a textile company located in Ieper, Belgium, by means of an asset purchase agreement. The assets purchased include all of the production equipment, computer equipment and the rights to all of the employee contracts. The purchase price of the assets of Schrurs NV was settled by the Company assuming outstanding debt of $1,172,081 (€861,551). The general decline in the textile business in Europe had left assets available at a favorable price for the Company. This acquisition resulted in a bargain purchase gain of $425,909 as follows:
	Fair value of assets acquired	$	1,797,121
	Fair value of debt assumed		(1,172,081	)
	Deferred income tax liability		(199,131	)
	Bargain purchase gain	$	425,909
	Under the terms of the asset purchase agreement, for a term of five years from the closing date of December 1, 2013, the repayment of the debt assumed by the Company shall be made in accordance with the terms of such debts and / or the repayment terms agreed upon between the seller and the respective creditors of the seller’s debts. On the fifth anniversary of the closing date, the aggregate outstanding amount under the seller’s debts at that point in time, shall be repaid in whole by the Company to the respective creditors of the seller’s debts. Between December 1, 2013 and December 28, 2013, no payments were made.
	At December 28, 2013 the debt assumed consists of the following, including a foreign exchange effect of $13,596 :
	Bank line of credit, bearing interest at 3.25%, repayable June 25, 2014	$	313,088
	Bank term loans, bearing interest ranging from 3.1% to 4.55%, repayable between
	September 2014 and August 2022.		712,881
	Loan payable on demand bearing interest at 4% per annum		90,897
	Loan payable on demand bearing no interest		68,810
			1,185,676
	Less: current portion		634,486
		$	551,190
	All of the above debt is denominated in Euros.

Commitments

Commitments	12 Months Ended
	Dec. 28, 2013
Commitments [Text Block]	'
	13	Commitments
	a)                     Leases
	The Company is committed to lease payments totaling approximately $1,930,000 for premises under lease. The minimum lease payments over the next five years are as follows:
	2014	$	296,579
	2015		209,539
	2016		209,539
	2017		209,539
	2018		209,539
	Total	$	1,134,735
	b)	National Research Council of Canada (“NRC”)
	Joint Collaboration Agreement
	In October 2007, the Company entered into a joint collaboration agreement with the NRC to continue to develop a patentable enzyme technology for the processing of hemp fibers. The agreement was for three years and expired on May 9, 2010. On February 19, 2010, the Company signed an amendment to the agreement to extend expiry to May 9, 2012. The Company intends to continue its joint collaboration of enzyme technology with the NRC; however the research will refocus on cellulose technology for the production of lignocellulosic ethanol. The NRC is to be paid as it conducts work on the joint collaboration. There are no further costs or other off-balance sheet liabilities associated with the NRC agreement.
	Technology License Agreement
	On November 1, 2006, the Company entered into a technology license agreement with the NRC. The license agreement provides the Company a worldwide license to use and sublicense the NRC technology called CRAiLAR ® . The Company paid an initial $20,525 (CAD $25,000) fee and will pay an ongoing royalty of 3% on sales of products derived from the CRAiLAR ® process to the NRC with a minimum annual payment set at $14,750 (CAD$15,000) per year in two installments. During the year ended December 28, 2013 the Company paid $7,375 (CAD$7,500) and accrued $7,375 (CAD$7,500) of the minimum annual royalty.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 28, 2013
Income Taxes [Text Block]	'
	14.                     Income Taxes
	As at December 28, 2013, the Company has estimated Canadian tax loss carry forwards for tax purposes of approximately $21,672,697 (2012 - $17,964,466) which expire between 2014 and 2033. Tax losses may be applied against future taxable income. Management has determined that the realization of the potential deferred tax assets resulting from these losses and other temporary differences is uncertain at this time, and cannot be viewed as more likely than not. Accordingly, the Company has recorded a full valuation allowance for the potential deferred tax asset.
	The reported income taxes differ from the amounts obtained by applying statutory rates to the loss before income taxes as follows:
			2013			2012
	Loss before income taxes	$	15,169,933		$	9,315,360
	Combined Canadian and US corporate tax rate		30.48%			28.85%
	Expected income tax recovery		(4,623,968	)		(2,654,878	)
	Increase (decrease) resulting from:
	Permanent differences and others		255,649			468,899
	Change in valuation allowance		5,155,729			2,324,647
	Impact of foreign exchange changes		(564,191	)		(101,609	)
	Impact of tax rate changes		(223,219	)		(37,059	)
	Future income tax expense	$	-		$	-
	The tax effects of temporary differences that give rise to the Company’s future tax asset (liability) are as follows:
			2013			2012
	Property and equipment and intangible assets	$	(168,845	)	$	89,513
	Research and development costs		999,811			806,068
	Share issue costs		165,590			196,805
	Other finance costs		1,883			124,546
	Loss carry forwards		10,999,463			5,824,372
			11,997,902			7,041,304
	Valuation allowance		(12,197,033	)		(7,041,304	)
		$	(199,131	)	$	-
	The Company’s non-capital losses expire as follows:
	Year of Expiry		Canada			USA
	2014	$	992,010		$	-
	2015		1,119,758			-
	2026		1,219,361			-
	2027		1,346,174			-
	2028		2,160,578			-
	2029		2,744,383			-
	2030		1,873,136			75,478
	2031		2,960,048			594,348
	2032		2,443,098			3,476,071
	2033		4,814,151			9,361,551
		$	21,672,697		$	13,507,448

Related_Parties_Transactions

Related Parties Transactions	12 Months Ended
	Dec. 28, 2013
Related Parties Transactions [Text Block]	'15.                     Related Party Transactions
	During the year ended December 28, 2013, $1,513,412 (2012 - $1,410,203) was incurred as remuneration to officers and directors of the Company. Of this amount, $1,455,282 (2012 - $1,410,203) is recorded in salaries and benefits expense.
	During the year ended December 28, 2013, $1,382,147 (2012 - $1,681,761) was recorded as stock-based compensation to officers and directors of the Company. Of this amount, $1,382,147 (2012 - $1,681,761) is recorded in salaries and benefits expense.
	Refer to Note 8.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 28, 2013
Subsequent Events [Text Block]	'
	16.                    Subsequent Events
	a)	On January 20, 2014, the TSX-V approved the Company’s proposal to issue 181,666 bonus shares at to Mr. Robert Edmunds in consideration of the CAD$545,000 convertible promissory note (Note 8).
	b)	Subsequent to year end, the Company received $2,197,153 (€1,597,000) pursuant to a loan agreement entered into with IKEA Supply AG (“IKEA”) with an effective date of November 29, 2013. The loan bears an interest rate of 1.9% per annum and is payable in monthly installments of € 11,000 from December 20, 2014 through June 20, 2016 with the remainder due in full on June 25, 2016. IKEA agreed to loan the Company $3,028,300 (€2,190,000) leaving $831,147 (€593,000) as an unused credit facility. The loan is secured by assets purchased with the proceeds, as well as a portion of the secured assets used to secure the 2013A Notes.
	c)	On March 20, 2014, the Company completed a private placement equity financing consisting of the sale of 2,515,000 units at $1.25 per unit for gross proceeds of $3,143,750. Each Unit is comprised of one common share and one-half of one transferable common share purchase warrant of the Company, and each whole warrant will entitle the holder thereof to purchase one additional common share of the Company at an exercise price of $1.75 per warrant share for a period of two years from closing, that is, until March 20, 2016. In addition, finders’ fees of an aggregate of 176,400 shares were issued to certain finders in conjunction with the closing of this private placement.

Summary_of_Significant_Account

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 28, 2013
Cash and Cash Equivalents [Policy Text Block]	'
	b)	Cash and Cash Equivalents
	Cash equivalents consist of cash on deposit and term deposits with original maturities of one year or less at the time of issuance. As at December 28, 2013, the Company held $15,000 (2012 - $20,000) in cash equivalents.
Inventory [Policy Text Block]	'
	c)	Inventory
	The raw flax fiber feedstock, decorticated fiber and Crailar fiber is valued at the lower of cost and market. All direct costs are capitalized to raw flax fiber inventory, decorticated fiber inventory and Crailar fiber.
	Seed inventory was valued at the lower of average cost and market. Cost comprised the cost to purchase seed and/or growing cost plus any related shipping costs.
	Other inventories, which consists of production consumables, are recorded at the lower of cost and replacement cost which approximates net realizable value.
Use of Estimates [Policy Text Block]	'
	d)	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. Significant areas requiring management’s estimates and assumptions are inventory costing and net realizable value, the expected future use and other impairment considerations of property and equipment, fair value of warrants, options, derivative liabilities, provision for income taxes, depreciation and financial instruments.
Property and Equipment [Policy Text Block]	'
	e)	Property and Equipment
	Property and equipment are stated at cost and are depreciated as follows:
		Automobiles	20% declining balance
		Computer equipment	30% declining balance
		Computer software	100% declining balance
		Equipment	30% declining balance
		Furniture and fixtures	20% declining balance
		Production Equipment	30% declining balance
		Leasehold improvements	Term of lease
		Website development	100% declining balance
	Depreciation is claimed at one-half of the regular rate in the year of addition, no depreciation is claimed in the year of disposal.
Intangible Assets [Policy Text Block]	'
	f)	Intangible Assets
	Intangible assets are stated at cost and are amortized as follows:
		Trademarks	5 year straight - line
		License Fee	10 year straight - line
		Patent	10 year straight – lin
Revenue Recognition [Policy Text Block]	'
	g)	Revenue Recognition
	Revenue is recognized when there is persuasive evidence of a sale arrangement, delivery to the customer has occurred, the fee is fixed and determinable, and collectability is considered probable.
Foreign Currency Translation [Policy Text Block]	'
	h)	Foreign Currency Translation
	The Company’s functional currency is Canadian dollars. The Company translates its financial statements to U.S. dollars using the following method:
	All assets and liabilities are translated into U.S. dollars at the exchange rate in effect at the year-end. Revenues and expenses are translated throughout the year at the weighted average exchange rate. Exchange gains or losses from such translations are included in accumulated comprehensive income (loss), as a separate component of stockholders’ equity.
	Foreign currency transaction gains and losses are included in the statement of operations and comprehensive loss.
Income Taxes [Policy Text Block]	'
	i)                        Income Taxes
	The Company utilizes the liability method of accounting for deferred income taxes. Under the liability method, deferred income taxes are determined based on the temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates. A valuation allowance is recorded when it is more likely than not that potential the future tax assets will not be realized.
Comprehensive Loss [Policy Text Block]	'
	j)                        Comprehensive Loss
	Comprehensive loss is the change in equity during a period resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Other comprehensive income (loss) comprises items of income and expenses that are not recognized in net loss as required or permitted by GAAP.
Stock-based Compensation [Policy Text Block]	'
	k)                        Stock-based Compensation
	The Company accounts for stock-based payment transactions in which an enterprise receives services in exchange for (a) equity instruments of the enterprise or (b) liabilities that are based on the fair value of the enterprise’s equity instruments or that may be settled by the issuance of such equity instruments. The Company uses the Black-Scholes option-pricing model to establish the fair-value of stock-based awards.
Earnings (Loss) Per Share [Policy Text Block]	'
	l)                        Earnings (Loss) Per Share
	Basic and diluted earnings (loss) per share are computed using the weighted average number of shares outstanding during the year. Common stock equivalents from stock options and warrants were excluded from the calculation of net loss per share for the years ended December 28, 2013 and December 31, 2012 as their effect is anti-dilutive.
Long-Lived Asset Impairment [Policy Text Block]	'
	m)                        Long-Lived Asset Impairment
	Long-lived assets of the Company are reviewed when changes in circumstances suggest their carrying value has become impaired. Management considers assets to be impaired if the carrying value exceeds the estimated discounted future projected cash flows to result from the use of the asset and its eventual disposition. If impairment is deemed to exist, the assets will be written down to fair value. Fair value is generally determined using a hierarchy of fair value methodologies under GAAP, primarily based on a discounted cash flow analysis.
Risk Management [Policy Text Block]	'
	n)                        Risk Management
	Currency risk. The Company is exposed to currency risk to the extent that certain inventory and equipment is purchased from Europe. The purchase price for such inventory and equipment is generally in Euros. The Company does not currently hedge its foreign currency exposure, and accordingly, is at risk for foreign currency exchange fluctuations. The Company and its subsidiaries do not have significant transactions or hold significant cash denominated in currencies other than their functional currencies.
	Credit risk. The risk in cash accounts is managed through the use of a major financial institution, which has high credit quality as determined by the rating agencies. As at December 28, 2013, $158,000 is due from a single customer and therefore 61% of receivables are exposed to concentration of credit risk.
	Interest rate risk. Approximately $1,026,000 of the Company’s debt bears interest at fluctuating rates. Consequentially the Company is exposed to interest rate fluctuations. The Company does not currently hedge its exposure to interest rate risk.
	Commodity price risk. Commodity price risk is the risk that the fair value of future cash flows will fluctuate because of changes in the market prices of commodities. The Company is exposed to commodity price risk as it purchases fiber feedstock from the flax producers in Europe. The Company purchases the short fiber waste product called “tow” and the price fluctuates based on supply. The Company has relationships with several short fiber producers and anticipates little issue in obtaining sufficient fiber for its needs. The Company does not currently enter into futures contracts or otherwise hedge its exposure to commodity price risk.
Research and Development [Policy Text Block]	'
	o)                        Research and Development
	Research and development costs are charged to operations as incurred.
Recent Pronouncements [Policy Text Block]	'
	p)                        Recent Pronouncements There are no recent pronouncements that are applicable to the Company.

Significant_Accounting_Policie1

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Property, Plant and Equipment, Declining Balances [Table Text Block]	'
		Automobiles	20% declining balance
		Computer equipment	30% declining balance
		Computer software	100% declining balance
		Equipment	30% declining balance
		Furniture and fixtures	20% declining balance
		Production Equipment	30% declining balance
		Leasehold improvements	Term of lease
		Website development	100% declining balance
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'
		Trademarks	5 year straight - line
		License Fee	10 year straight - line
		Patent	10 year straight – lin

Inventory_Tables

Inventory (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Inventory, Current [Table Text Block]	'
			28-Dec-13		31-Dec-12
	CRAiLAR fiber	$	186,464	$	-
	Decorticated fiber		252,263		51,504
	Flax seed		-		1,172,155
	Raw flax fiber feedstock		369,590		1,680,993
	Other		136,723		-
		$	945,040	$	2,904,652
Schedule of Inventory Write-downs [Table Text Block]	'
			28-Dec-13		31-Dec-12
	CRAiLAR fiber	$	274,297	$	-
	Decorticated fiber		196,861		-
	Flax seed		1,891,217		303,663
	Raw flax fiber feedstock		2,279,887		-
		$	4,642,262	$	303,663

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 28, 2013
Property, Plant and Equipment [Table Text Block]	'
							Net Book Value		Net Book Value
					Accumulated		December 28,		December 31,
			Cost		Depreciation		2013		2012
	Automobiles	$	58,743	$	8,876	$	49,867	$	57,559
	Computer equipment		126,192		69,019		57,180		48,398
	Equipment		754,902		98,556		656,346		359,445
	Equipment held for sale		70,000		-		70,000		105,045
	Furniture and fixtures		62,339		36,918		25,421		29,980
	Leasehold improvements		6,327,333		615,459		5,498,633		4,979,548
	Production equipment		5,095,961		277,681		4,818,280		-
	Production equipment in construction		6,060,849		-		6,060,849		7,606,837
	Website development costs		121,330		117,365		3,436		61,876
		$	18,464,408	$	1,224,396	$	17,240,012	$	13,248,688

Intangible_Assets_Tables

Intangible Assets (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Intangible Assets and Goodwill [Table Text Block]	'
					Accumulated		Net Book Value		Net Book Value
			Cost		Amortization		28-Dec-13		31-Dec-12
	Patents	$	158,367	$	72,885	$	85,482	$	77,961
	Trademarks		121,968		93,903		28,065		7,639
	License fee		62,710		20,712		41,998		9,019
		$	343,045	$	187,500	$	155,545	$	94,619

Derivative_liability_Tables

Derivative liability (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Derivative Instruments [Table Text Block]	'
					December 28,		December 31,
			Exercise price		2013		2012
	275,506 warrants expired on May 19, 2013		US$1.25	$	-	$	257,564
	533,887 warrants expiring on Oct 14, 2014		US$3.45		-		230,471
				$	-	$	488,035
Schedule of Derivative Instruments, Valuation Assumptions [Table Text Block]	'
		28-Dec-13	31-Dec-12
	Volatility	60%	57% - 83%
	Dividend yield	-	-
	Risk-free interest rate	0.09%	0.14 – 0.72%
	Expected life	0.62 years	0.38 – 1.18 yrs.

Notes_Payable_Tables

Notes Payable (Tables)	12 Months Ended
	Dec. 28, 2013
Convertible Note Payable [Table Text Block]	'
			28-Dec-13
	Principal	$	669,335
	Interest		23,781
	Repayment		(47,885	)
	Beneficial conversion feature		(188,140	)
	Accretion expense		33,495
	Effect of foreign exchange		(13,872	)
		$	476,614

Long_term_debt_Tables

Long term debt (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Long-term Debt Instruments [Table Text Block]	'
			28-Dec-13			31-Dec-12
	Balance, beginning	$	10,051,262		$	-
	Convertible debenture issued		8,307,249			10,051,262
	Discount on debentures		(754,829	)		-
	Amendment of debentures – conversion price		(79,931	)		-
	Accretion expense		94,030			-
	Effect of foreign exchange		(943,095	)		-
	Balance, ending	$	16,674,686		$	10,051,262
Schedule of Deferred debt issuance costs [Table Text Block]	'
			28-Dec-13			31-Dec-12
	Balance, beginning	$	1,024,294		$	-
	Issuance costs – cash		886,733			1,083,936
	Issuance costs – warrants		66,278			-
	Issuance costs allocated to additional paid in capital		(102,670	)		-
	Amortization of issuance costs		(346,789	)		(59,642	)
	Effect of foreign exchange		(85,823	)		-
		$	1,442,023		$	1,024,294

Capital_Stock_Tables

Capital Stock (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	'
				Weighted Average
				Remaining
		Range of Exercise Prices	Number of Warrants	Contractual Life
		$0.70 - $3.45	6,887,580	3.60 years
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	'
					Weighted-
					Average
			Shares		Exercise Price
	Warrants outstanding at December 31, 2011		3,294,229		3.57
	Warrants granted during the year		541,167		3.42
	Warrants expired during the year		(29,957	)	1.38
	Warrants exercised during the year		(648,591	)	1.32
	Warrants outstanding at December 31, 2012		3,156,848		4.02
	Warrants granted during the year		6,353,963		0.96
	Warrants expired during the year		(2,585,731	)	4.17
	Warrants exercised during the year		(37,500	)	1.25
	Warrants outstanding at December 28, 2013		6,887,580		1.15

Stock_Options_Tables

Stock Options (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
						Weighted-Average
			Shares			Exercise Price
	Options outstanding, December 31, 2011		5,281,945		$	1.48
	Options exercised during the year		(821,229	)		1.06
	Options granted during the year		1,974,500			2.25
	Options cancelled during the year		(19,173	)		1.93
	Options outstanding, December 31, 2012		6,416,043			1.77
	Options exercised during the year		(196,000	)		0.98
	Options granted during the year		285,000			2.25
	Options cancelled/expired during the year		(36,244	)		2.09
	Options outstanding, December 28, 2013		6,468,799			1.81
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
	December 28, 2013
	Options Outstanding				Options Exercisable
			Weighted
			Average	Weighted		Weighted
	Range of		Remaining	Average		Average
	Exercise	Number	Contractual	Exercise	Number	Exercise
	Prices	Outstanding	Life (yr.)	Price	Exercisable	Price
	$0.87 - $3.05	6,468,799	2.46	$1.81	6,301,720	$1.81
	December 31, 2012
	Options Outstanding				Options Exercisable
			Weighted
			Average	Weighted		Weighted
	Range of		Remaining	Average		Average
	Exercise	Number	Contractual	Exercise	Number	Exercise
	Prices	Outstanding	Life (yr.)	Price	Exercisable	Price
	$0.87 - $3.05	6,416,043	4.98	$1.77	4,304,990	$1.69
Original 2011 Fixed Share Option Plan [Member]	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
			Year ended
			31-Dec-12
	Risk-free interest rates		0.78% to 0.92%
	Volatility factor		88% to 89%
	Expected life of options, in years		5
	Weighted average fair value of options granted		$2.14
Amended 2011 Fixed Share Option Plan [Member]	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
			Year ended			Year ended
			28-Dec-13			31-Dec-12
	Risk-free interest rates		0.75% to 0.90%			0.18% to 0.39%
	Volatility factor		63% to 66%			74% to 75%
	Expected life of options, in years		4.2			4.17
	Weighted average fair value of options granted		$1.15			$1.34
2010 Fixed Share Option Plan [Member]	'
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
			Year ended
			31-Dec-12
	Risk-free interest rates		0.90% to 0.1.56%
	Volatility factor		68% to 91%
	Expected life of options, in years		5
	Weighted average fair value of options granted		$1.66

Business_Combination_Tables

Business Combination (Tables)	12 Months Ended
	Dec. 28, 2013
Business Combination, Segment Allocation [Table Text Block]	'
	Fair value of assets acquired	$	1,797,121
	Fair value of debt assumed		(1,172,081	)
	Deferred income tax liability		(199,131	)
	Bargain purchase gain	$	425,909
Business Combination, Separately Recognized Transactions [Table Text Block]	'
	Bank line of credit, bearing interest at 3.25%, repayable June 25, 2014	$	313,088
	Bank term loans, bearing interest ranging from 3.1% to 4.55%, repayable between
	September 2014 and August 2022.		712,881
	Loan payable on demand bearing interest at 4% per annum		90,897
	Loan payable on demand bearing no interest		68,810
			1,185,676
	Less: current portion		634,486
		$	551,190

Commitments_Tables

Commitments (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]	'
	2014	$	296,579
	2015		209,539
	2016		209,539
	2017		209,539
	2018		209,539
	Total	$	1,134,735

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 28, 2013
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	'
			2013			2012
	Loss before income taxes	$	15,169,933		$	9,315,360
	Combined Canadian and US corporate tax rate		30.48%			28.85%
	Expected income tax recovery		(4,623,968	)		(2,654,878	)
	Increase (decrease) resulting from:
	Permanent differences and others		255,649			468,899
	Change in valuation allowance		5,155,729			2,324,647
	Impact of foreign exchange changes		(564,191	)		(101,609	)
	Impact of tax rate changes		(223,219	)		(37,059	)
	Future income tax expense	$	-		$	-
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
			2013			2012
	Property and equipment and intangible assets	$	(168,845	)	$	89,513
	Research and development costs		999,811			806,068
	Share issue costs		165,590			196,805
	Other finance costs		1,883			124,546
	Loss carry forwards		10,999,463			5,824,372
			11,997,902			7,041,304
	Valuation allowance		(12,197,033	)		(7,041,304	)
		$	(199,131	)	$	-
Summary of Operating Loss Carryforwards [Table Text Block]	'
	Year of Expiry		Canada			USA
	2014	$	992,010		$	-
	2015		1,119,758			-
	2026		1,219,361			-
	2027		1,346,174			-
	2028		2,160,578			-
	2029		2,744,383			-
	2030		1,873,136			75,478
	2031		2,960,048			594,348
	2032		2,443,098			3,476,071
	2033		4,814,151			9,361,551
		$	21,672,697		$	13,507,448

Nature_of_Operations_and_Basis1

Nature of Operations and Basis of Presentation (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 28, 2013
Cumulative Deficit	$47,422,847
Proceeds from (Payments for) Other Financing Activities	$2,119,146

Significant_Accounting_Policie2

Significant Accounting Policies (Narrative) (Details) (USD $)	Dec. 28, 2013	Dec. 31, 2012
Cash Equivalents, at Carrying Value	$15,000	$20,000
Credit risk, amount at risk	158,000	'
Credit risk, percentage at risk	61.00%	'
Interest risk, amount at risk	$1,026,000	'

Derivative_liability_Narrative

Derivative liability (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Class of Warrant or Right, Exercises in Period	37,500	648,591
Adjustments to additional paid in capital, derivative liability	$35,190	'

Notes_Payable_Narrative_Detail

Notes Payable (Narrative) (Details)

12 Months Ended

51 Months Ended

12 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2011

Dec. 28, 2013

Dec. 28, 2013

Oct. 31, 2013

Oct. 31, 2013

Dec. 28, 2013

Dec. 28, 2013

Oct. 31, 2013

Oct. 31, 2013

Nov. 30, 2013

Nov. 30, 2013

Oct. 31, 2013

Oct. 31, 2013

Dec. 28, 2013

Dec. 28, 2013

Oct. 31, 2013

Dec. 28, 2013

USD ($)

USD ($)

USD ($)

USD ($)

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Mr. Robert Edmunds [Member]

Mr. Robert Edmunds [Member]

Mr. Robert Edmunds [Member]

Mr. Robert Edmunds [Member]

Mr. Robert Edmunds - 2 [Member]

Mr. Robert Edmunds - 2 [Member]

Mr. Jason Finnis [Member]

Mr. Jason Finnis [Member]

Mr. Jason Finnis [Member]

Mr. Jason Finnis [Member]

Mr. Jason Finnis [Member]

Mr. Jason Finnis [Member]

Mr. Kenneth Barker [Member]

Mr. Kenneth Barker [Member]

USD ($)

CAD

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

Convertible Promissory Notes [Member]

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

USD ($)

USD ($)

Convertible debenture issued

$8,307,249

$10,051,262

'

'

'

'

$467,369

500,000

'

'

$42,255

45,000

'

'

$96,180

100,000

'

'

$50,000

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

20.00%

20.00%

'

'

'

'

'

'

12.00%

12.00%

'

'

12.00%

'

Bonus common shares issued

'

'

'

'

'

'

181,666

181,666

'

'

'

'

'

'

'

'

'

'

'

'

Accrued Interest

'

'

'

'

'

'

'

'

20,896

22,667

'

'

'

'

'

'

1,210

1,290

'

1,234

Convertible Debt, Current

'

'

'

'

'

'

'

'

532,576

567,267

'

'

'

'

'

'

48,132

51,290

'

51,234

Repayments of Convertible Debt

'

'

'

'

'

'

'

'

'

'

'

'

48,326

50,000

'

'

'

'

'

'

Interest Paid

1,347,905

9,435

0

'

'

'

'

'

'

'

'

'

441

460

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

'

$0.60

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Outstanding, Weighted Average Exercise Price

$1.15

$4.02

$1.15

$3.57

$0.70

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Weighted Average Remaining Contractual Term

'

'

'

'

'5 years

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Beneficial Conversion Feature

188,140

'

'

'

188,140

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accretion expense

33,495

'

33,495

'

33,495

34,483

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Beneficial Conversion Feature, After Accretion

'

'

'

'

$154,645

165,517

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long_term_debt_Narrative_Detai

Long term debt (Narrative) (Details)

1 Months Ended

12 Months Ended

51 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 28, 2013

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 28, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Jul. 26, 2013

Dec. 28, 2013

CAD

USD ($)

USD ($)

USD ($)

Warrants [Member]

Warrants [Member]

Convertible Notes [Member]

Convertible Notes [Member]

Convertible Notes - 2012 [Member]

Convertible Notes - 2012 [Member]

Convertible Notes - 2012 [Member]

Convertible Notes - 2012 [Member]

Convertible Notes - 2013 [Member]

Convertible Notes - 2013 [Member]

Convertible Notes - 2013 [Member]

Convertible Notes - 2013 [Member]

Guaranty and Security Agreement - amendment [Member]

Closing a subordinated convertible debenture [Member]

Closing a subordinated convertible debenture [Member]

Closing a subordinated convertible debenture [Member]

Closing a subordinated convertible debenture [Member]

Closing a subordinated convertible debenture [Member]

Closing a subordinated convertible debenture [Member]

Closing a subordinated convertible debenture [Member]

Naturally Advanced Technologies [Member]

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

USD ($)

CAD

Agent warrants [Member]

Brokers Warrants [Member]

USD ($)

USD ($)

CAD

Warrants [Member]

Warrants [Member]

Convertible Notes - 2013 [Member]

Convertible Notes - 2013 [Member]

Convertible Notes - 2013 [Member]

USD ($)

USD ($)

USD ($)

USD ($)

CAD

USD ($)

CAD

CAD

Notes Issued

'

'

'

'

'

'

'

'

$10,051,262

10,000,000

'

'

$4,943,643

5,000,000

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

10.00%

10.00%

'

'

10.00%

10.00%

'

'

'

'

'

'

'

'

'

10.00%

'

Interest Payable

'

'

'

'

'

'

'

'

277,513

277,397

264,143

281,471

114,412

121,918

'

'

'

'

'

'

'

80,893

86,200

'

'

Payments of deferred debt issuance costs

'

886,733

1,083,936

'

'

'

'

'

1,083,936

1,019,069

'

'

427,049

487,830

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

'

'

'

$2.85

2.9

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.25

'

Business Acquisition, Cost of Acquired Entity, Purchase Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,922,240

'

'

'

'

'

'

'

5,500,000

Deferred financing costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

337,469

'

'

'

'

'

'

'

'

'

Proceeds from Convertible Debt

'

8,307,249

10,051,262

18,358,511

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,363,606

3,535,000

'

'

Class of Warrant or Right, Grants in Period, Net of Forfeitures

'

6,353,963

541,167

'

'

'

'

'

'

'

'

'

'

'

192,360

'

'

2,828,000

2,828,000

'

'

'

'

'

'

Class of Warrant or Right, Grants in Period, Exercise Price

0.7

'

$3.45

'

'

'

'

'

'

'

'

'

'

'

'

$1.25

$1.25

$2

'

'

'

'

'

'

'

Warrants Issued During Period, Value

'

'

280,496

'

'

'

'

'

'

'

'

'

'

'

66,278

'

79,931

974,387

1,003,910

754,829

777,700

2,295,309

2,757,300

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

'

'

'

'

0.00%

0.00%

'

'

'

'

'

'

'

'

'

0.00%

0.00%

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

'

'

'

'

60.00%

'

'

'

'

'

'

'

'

'

'

56.00%

56.00%

56.00%

56.00%

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

'

'

'

'

0.09%

'

'

'

'

'

'

'

'

'

'

0.59%

0.59%

0.59%

0.59%

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

'

'

'

'

'0 years 7 months 13 days

'

'

'

'

'

'

'

'

'

'

'2 years 9 months 29 days

'2 years 5 months 1 day

'2 years 9 months 29 days

'2 years 9 months 29 days

'

'

'

'

'

'

Amortization of debt discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

94,030

'

'

'

'

'

'

'

'

Deferred Issuance costs for convertible debenture

'

886,733

1,083,936

1,970,669

'

'

'

'

'

'

'

'

373,861

'

440,139

'

'

'

'

'

'

'

'

'

'

Additional Paid-in Capital

'

9,934,322

7,061,406

9,934,322

'

'

'

'

'

'

'

'

102,670

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of deferred debt issuance costs

'

$346,789

$59,642

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Capital_Stock_Narrative_Detail

Capital Stock (Narrative) (Details)

1 Months Ended

12 Months Ended

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

Dec. 31, 2012

USD ($)

CAD

USD ($)

USD ($)

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Officers and directors [Member]

Officers and directors [Member]

Options for Employees and Consultants [Member]

Options for Employees and Consultants [Member]

Options for Employees and Consultants [Member]

Options for Employees and Consultants [Member]

Other Warrants [Member]

Other Warrants [Member]

Other Warrants [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

USD ($)

USD ($)

USD ($)

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

'

'

196,000

821,229

'

'

'

'

166,000

565,635

196,000

821,299

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price

'

'

$0.98

$1.06

$0.87

'

$1.17

'

'

'

'

'

$0.87

$2.77

'

'

'

Proceeds from Stock Options Exercised

'

'

'

'

'

'

'

'

$163,020

$608,376

$192,871

$868,768

'

'

'

'

'

Class of Warrant or Right, Exercises in Period

'

'

37,500

648,591

'

'

'

'

'

'

'

'

'

'

648,591

'

'

Class of Warrant or Right, Exercises in Period, Exercise Price

'

'

$1.25

'

'

'

'

'

'

'

'

'

'

'

'

$1.20

$1.38

Proceeds from Warrant Exercises

'

'

46,875

'

'

'

'

'

'

'

'

'

'

'

859,285

'

'

Units Issued During Period, Units

3,333,333

3,333,333

'

1,067,774

'

'

'

'

'

'

'

'

'

'

'

'

'

Units Issued During Period, Value

'

'

'

2,359,780

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Units Issued During Period

1,879,400

2,000,000

'

64,050

'

'

'

'

'

'

'

'

'

'

'

'

'

Units Issued During Period, Underlying Shares

1

1

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

Units Issued During Period, Underlying Warrants

0.5

0.5

'

0.5

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Grants in Period, Exercise Price

'

0.7

'

$3.45

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Grants in Period, Contractual Term

'5 years

'5 years

'

'2 years

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants Issued During Period, Value

'

'

'

$280,496

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate

'

'

'

'

'

66.00%

'

67.00%

'

'

'

'

'

'

'

'

'

Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate

'

'

'

'

'

0.23%

'

25.00%

'

'

'

'

'

'

'

'

'

Stock_Options_Narrative_Detail

Stock Options (Narrative) (Details) (USD $)

12 Months Ended

51 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 28, 2013

Dec. 28, 2013

Dec. 31, 2012

Jun. 26, 2012

Sep. 30, 2011

Dec. 28, 2013

Dec. 31, 2012

Sep. 09, 2013

Sep. 08, 2013

Jun. 26, 2012

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2012

Sep. 30, 2010

Dec. 28, 2013

Dec. 31, 2012

Dec. 28, 2013

Dec. 31, 2012

Original 2011 Fixed Share Option Plan [Member]

Original 2011 Fixed Share Option Plan [Member]

Original 2011 Fixed Share Option Plan [Member]

Original 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

Amended 2011 Fixed Share Option Plan [Member]

2010 Fixed Share Option Plan [Member]

2010 Fixed Share Option Plan [Member]

2010 Fixed Share Option Plan [Member]

2010 Fixed Share Option Plan [Member]

2010 Fixed Share Option Plan [Member]

2010 Fixed Share Option Plan [Member]

2010 Fixed Share Option Plan [Member]

Consulting and contract labour [Member]

Consulting and contract labour [Member]

Salaries and benefits [Member]

Salaries and benefits [Member]

Consulting and contract labour [Member]

Consulting and contract labour [Member]

Salaries and benefits [Member]

Salaries and benefits [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning of Period

6,416,043

5,281,945

'

6,468,799

'

'

8,224,240

8,224,240

'

'

8,894,539

8,512,976

8,512,976

'

'

'

'

'

'

7,057,640

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

285,000

1,974,500

'

'

0

125,000

'

'

285,000

1,849,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit

$0.87

$0.87

'

'

$1.31

'

'

'

$2.24

$2.23

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit

$3.05

$3.05

'

'

$2.09

'

'

'

$2.30

$2.31

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$2.25

$2.25

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value

'

'

'

'

$0

$210,136

'

'

$328,757

$1,973,289

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period

'

'

'

'

25,000

85,423

'

'

2,253,762

303,250

'

'

'

'

'

'

'

500,000

862,356

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

196,000

821,229

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation

$2,004,647

$2,397,819

$8,142,956

'

$38,273

$210,275

'

'

$1,889,307

$325,724

'

'

'

$306,602

$45,810

$1,582,705

$279,914

$77,067

$1,861,820

'

$0

$259,601

$77,067

$1,602,219

Business_Combination_Narrative

Business Combination (Narrative) (Details)	12 Months Ended		51 Months Ended
	Dec. 28, 2013	Dec. 31, 2012	Dec. 28, 2013	Dec. 01, 2013	Dec. 01, 2013
	USD ($)	USD ($)	USD ($)	USD ($)	EUR (€)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	'	'	'	$1,172,081	€ 861,551
Bargain purchase	425,909	0	425,909	'	'
Business Combination, Liabilities Assumed, Foreign Exchange Effect	$13,596	'	'	'	'

Commitments_Narrative_Details

Commitments (Narrative) (Details)	12 Months Ended
	Dec. 28, 2013	Dec. 28, 2013	Dec. 28, 2013
	Lease for industrial and office building [Member]	NRC Technology License Agreement [Member]	NRC Technology License Agreement [Member]
	USD ($)	USD ($)	CAD
Long-term Purchase Commitment, Amount	$1,930,000	$14,750	15,000
Payments of Commitments	'	20,525	25,000
Royalty Percentage	'	3	'
Royalty Expense	'	$7,375	7,500

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (Canada [Member], USD $)	Dec. 28, 2013	Dec. 31, 2012
Canada [Member]	'	'
Operating Loss Carryforwards	$21,672,697	$17,964,466

Related_Parties_Transactions_N

Related Parties Transactions (Narrative) (Details) (USD $)	12 Months Ended		51 Months Ended
	Dec. 28, 2013	Dec. 31, 2012	Dec. 28, 2013
Share-based Compensation	$2,004,647	$2,397,819	$8,142,956
Officers and directors [Member]	'	'	'
Related Party Transaction, Amounts of Transaction	1,513,412	1,410,203	'
Share-based Compensation	1,382,147	1,681,761	'
Officers and directors [Member] | Salaries and benefits [Member]	'	'	'
Related Party Transaction, Amounts of Transaction	1,455,282	1,410,203	'
Share-based Compensation	$1,382,147	$1,681,761	'

Subsequent_Events_Narrative_De

Subsequent Events (Narrative) (Details)	1 Months Ended	12 Months Ended		51 Months Ended	12 Months Ended
	Dec. 28, 2013	Dec. 28, 2013	Dec. 31, 2012	Dec. 28, 2013	Dec. 28, 2013	Dec. 28, 2013	Dec. 28, 2013	Dec. 28, 2013
	CAD	USD ($)	USD ($)	USD ($)	Demand convertible promissory note in favor of Mr. Robert Edmunds (after period end) [Member]	Acquisition of a European facility (after period end) [Member]	Acquisition of a European facility (after period end) [Member]	Private Placement Equity Financing (after period end) [Member]
					USD ($)	USD ($)	EUR (€)	USD ($)
Bonus common shares issued	'	'	'	'	181,666	'	'	'
Proceeds from Convertible Debt	'	$8,307,249	$10,051,262	$18,358,511	$545,000	'	'	'
Notes Issued	'	'	'	'	'	2,197,153	1,597,000	'
Debt Instrument, Interest Rate, Stated Percentage	'	'	'	'	'	1.90%	1.90%	'
Debt Instrument, Periodic Payment	'	'	'	'	'	11,000	'	'
Secured Long-term Debt	'	'	'	'	'	3,028,300	2,190,000	'
Unused credit facility	'	'	'	'	'	831,147	593,000	'
Units Issued During Period, Units	3,333,333	'	1,067,774	'	'	'	'	2,515,000
Units Issued During Period, Per Unit Amount	'	'	'	'	'	'	'	$1.25
Units Issued During Period, Value	'	'	$2,359,780	'	'	'	'	$3,143,750
Units Issued During Period, Underlying Shares	1	'	1	'	'	'	'	1
Units Issued During Period, Underlying Warrants	0.5	'	0.5	'	'	'	'	0.5
Class of Warrant or Right, Grants in Period, Exercise Price	0.7	'	$3.45	'	'	'	'	$1.75
Class of Warrant or Right, Grants in Period, Contractual Term	'5 years	'	'2 years	'	'	'	'	'2 years
Stock Issued During Period, Finders' Fees	'	'	'	'	'	'	'	176,400

Schedule_of_Property_Plant_and

Schedule of Property, Plant and Equipment, Declining Balances (Details)	12 Months Ended
	Dec. 28, 2013
Automobiles [Member]	'
Property and Equipment, Depreciation Rate	20.00%
Computer equipment [Member]	'
Property and Equipment, Depreciation Rate	30.00%
Computer software [Member]	'
Property and Equipment, Depreciation Rate	100.00%
Equipment [Member]	'
Property and Equipment, Depreciation Rate	30.00%
Furniture and fixtures [Member]	'
Property and Equipment, Depreciation Rate	20.00%
Production equipment [Member]	'
Property and Equipment, Depreciation Rate	30.00%
Website development [Member]	'
Property and Equipment, Depreciation Rate	100.00%

Schedule_of_FiniteLived_Intang

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)	12 Months Ended
	Dec. 28, 2013
Patent [Member]	'
Finite-Lived Intangible Asset, Useful Life	'10 years
Trademarks [Member]	'
Finite-Lived Intangible Asset, Useful Life	'5 years
License Fee [Member]	'
Finite-Lived Intangible Asset, Useful Life	'10 years

Schedule_of_Inventory_Current_

Schedule of Inventory, Current (Details) (USD $)	Dec. 28, 2013	Dec. 31, 2012
Inventory, Net	$945,040	$2,904,652
CRAiLAR fiber [Member]	'	'
Inventory, Net	186,464	0
Decorticated fiber [Member]	'	'
Inventory, Net	252,263	51,504
Flax seed [Member]	'	'
Inventory, Net	0	1,172,155
Raw flaw fiber feedstock [Member]	'	'
Inventory, Net	369,590	1,680,993
Others [Member]	'	'
Inventory, Net	$136,723	$0

Schedule_of_Inventory_Writedow

Schedule of Inventory Write-downs (Details) (USD $)	12 Months Ended		51 Months Ended
	Dec. 28, 2013	Dec. 31, 2012	Dec. 28, 2013
Impairment of inventory	$4,642,262	$303,663	$4,945,925
CRAiLAR fiber [Member]	'	'	'
Impairment of inventory	274,297	0	'
Decorticated fiber [Member]	'	'	'
Impairment of inventory	196,861	0	'
Flax seed [Member]	'	'	'
Impairment of inventory	1,891,217	303,663	'
Raw flaw fiber feedstock [Member]	'	'	'
Impairment of inventory	$2,279,887	$0	'

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details) (USD $)	Dec. 28, 2013	Dec. 31, 2012
Property, Plant and Equipment, Gross	$18,464,408	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	1,224,396	'
Property, Plant and Equipment, Net	17,240,012	13,248,688
Automobiles [Member]	'	'
Property, Plant and Equipment, Gross	58,743	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	8,876	'
Property, Plant and Equipment, Net	49,867	57,559
Computer equipment [Member]	'	'
Property, Plant and Equipment, Gross	126,192	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	69,019	'
Property, Plant and Equipment, Net	57,180	48,398
Equipment [Member]	'	'
Property, Plant and Equipment, Gross	754,902	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	98,556	'
Property, Plant and Equipment, Net	656,346	359,445
Equipment held for sale [Member]	'	'
Property, Plant and Equipment, Gross	70,000	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	0	'
Property, Plant and Equipment, Net	70,000	105,045
Furniture and fixtures [Member]	'	'
Property, Plant and Equipment, Gross	62,339	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	36,918	'
Property, Plant and Equipment, Net	25,421	29,980
Leasehold improvements [Member]	'	'
Property, Plant and Equipment, Gross	6,327,333	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	615,459	'
Property, Plant and Equipment, Net	5,498,633	4,979,548
Production equipment [Member]	'	'
Property, Plant and Equipment, Gross	5,095,961	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	277,681	'
Property, Plant and Equipment, Net	4,818,280	0
Production equipment in construction [Member]	'	'
Property, Plant and Equipment, Gross	6,060,849	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	0	'
Property, Plant and Equipment, Net	6,060,849	7,606,837
Website development [Member]	'	'
Property, Plant and Equipment, Gross	121,330	'
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	117,365	'
Property, Plant and Equipment, Net	$3,436	$61,876

Schedule_of_Intangible_Assets_

Schedule of Intangible Assets and Goodwill (Details) (USD $)	Dec. 28, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets, Gross	$343,045	'
Finite-Lived Intangible Assets, Accumulated Amortization	187,500	'
Finite-Lived Intangible Assets, Net	155,545	94,619
Patent [Member]	'	'
Finite-Lived Patents, Gross	158,367	'
Finite-Lived Intangible Assets, Accumulated Amortization	72,885	'
Finite-Lived Intangible Assets, Net	85,482	77,961
Trademarks [Member]	'	'
Finite-Lived Trademarks, Gross	121,968	'
Finite-Lived Intangible Assets, Accumulated Amortization	93,903	'
Finite-Lived Intangible Assets, Net	28,065	7,639
License Fee [Member]	'	'
Finite-Lived License Agreements, Gross	62,710	'
Finite-Lived Intangible Assets, Accumulated Amortization	20,712	'
Finite-Lived Intangible Assets, Net	$41,998	$9,019

Schedule_of_Derivative_Instrum

Schedule of Derivative Instruments (Details) (USD $)	Dec. 28, 2013	Dec. 31, 2012	Dec. 31, 2011
Class of Warrant or Right, Outstanding	6,887,580	3,156,848	3,294,229
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price	$1.15	$4.02	$3.57
Expiring on May 19, 2013 [Member]	'	'	'
Class of Warrant or Right, Outstanding	275,506	'	'
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price	$1.25	'	'
Warrants and Rights Outstanding	$0	$257,564	'
Expiring on October 14, 2014 [Member]	'	'	'
Class of Warrant or Right, Outstanding	533,887	'	'
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price	$3.45	'	'
Warrants and Rights Outstanding	0	230,471	'
Warrants [Member]	'	'	'
Warrants and Rights Outstanding	$0	$488,035	'

Schedule_of_Derivative_Instrum1

Schedule of Derivative Instruments, Valuation Assumptions (Details) (Warrants [Member])	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	60.00%	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.09%	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'0 years 7 months 13 days	'
Minimum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	'	57.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	'	0.14%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'	'0 years 4 months 17 days
Maximum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	'	83.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	'	0.72%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	'	'1 year 2 months 5 days

Convertible_Note_Payable_Detai

Convertible Note Payable (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Principal	$669,335	'
Interest	23,781	'
Repayment	-47,885	'
Beneficial conversion feature	-188,140	'
Accretion expense	33,495	'
Effect of foreign exchange	-13,872	'
Note payable	$476,614	$0

Schedule_of_Longterm_Debt_Inst

Schedule of Long-term Debt Instruments (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Long Term Debt, beginning of period	$10,051,262	$0
Convertible debenture issued	8,307,249	10,051,262
Discount on debentures	-754,829	0
Amendment of debentures conversion price	-79,931	0
Accretion expense	94,030	0
Effect of foreign exchange	-943,095	0
Long Term Debt, end of period	$16,674,686	$10,051,262

Schedule_of_Deferred_debt_issu

Schedule of Deferred debt issuance costs (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Deferred Debt Issuance Costs, beginning of period	$1,024,294	$0
Issuance costs - cash	886,733	1,083,936
Issuance costs warrants	66,278	0
Issuance costs allocated to additional paid in capital	-102,670	0
Amortization of issuance costs	-346,789	-59,642
Effect of foreign exchange	-85,823	0
Deferred Debt Issuance Costs, end of period	$1,442,023	$1,024,294

Schedule_of_Stockholders_Equit

Schedule of Stockholders' Equity Note, Warrants or Rights (Details)	Dec. 28, 2013	Dec. 31, 2012	Dec. 31, 2011
Class of Warrant or Right, Outstanding	6,887,580	3,156,848	3,294,229
Range 1 [Member]	'	'	'
Class of Warrant or Right, Outstanding	6,887,580	'	'
Class of Warrant or Right, Weighted Average Remaining Contractual Term	'3 years 7 months 6 days	'	'
Range 1 [Member] | Minimum [Member]	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	0.7	'	'
Range 1 [Member] | Maximum [Member]	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	3.45	'	'

Schedule_of_Stockholders_Equit1

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Class of Warrant or Right, Outstanding, Beginning of Period	3,156,848	3,294,229
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, Beginning of Period	$4.02	$3.57
Class of Warrant or Right, Exercises in Period	-37,500	-648,591
Class of Warrant or Right, Exercises in Period, Weighted Average Exercise Price	$1.25	$1.32
Class of Warrant or Right, Expirations in Period	-2,585,731	-29,957
Class of Warrant or Right, Expirations in Period, Weighted Average Exercise Price	$4.17	$1.38
Class of Warrant or Right, Grants in Period, Net of Forfeitures	6,353,963	541,167
Class of Warrant or Right, Grants in Period, Weighted Average Exercise Price	$0.96	$3.42
Class of Warrant or Right, Outstanding, End of Period	6,887,580	3,156,848
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price, End of Period	$1.15	$4.02

Schedule_of_Sharebased_Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Original 2011 Fixed Share Option Plan [Member]	'	'
Risk-free interest rate, Minimum	'	0.78%
Risk-free interest rate, Maximum	'	0.92%
Volatility factor, Minimum	'	88.00%
Volatility factor, Maximum	'	89.00%
Expected life of options, in years	'	'5 years
Weighted average fair value of options granted	'	$2.14
Amended 2011 Fixed Share Option Plan [Member]	'	'
Risk-free interest rate, Minimum	0.75%	0.18%
Risk-free interest rate, Maximum	0.90%	0.39%
Volatility factor, Minimum	63.00%	74.00%
Volatility factor, Maximum	66.00%	75.00%
Expected life of options, in years	'4 years 2 months 12 days	'4 years 2 months 1 day
Weighted average fair value of options granted	$1.15	$1.34
2010 Fixed Share Option Plan [Member]	'	'
Risk-free interest rate, Minimum	'	0.90%
Risk-free interest rate, Maximum	'	0.10%
Volatility factor, Minimum	'	68.00%
Volatility factor, Maximum	'	91.00%
Expected life of options, in years	'	'5 years
Weighted average fair value of options granted	'	$1.66

Schedule_of_Sharebased_Compens

Schedule of Share-based Compensation, Stock Options, Activity (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning of Period	6,416,043	5,281,945
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning of Period	$1.77	$1.48
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	285,000	1,974,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$2.25	$2.25
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	-196,000	-821,229
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price	$0.98	$1.06
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period	-36,244	-19,173
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price	$2.09	$1.93
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, End of Period	6,468,799	6,416,043
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, End of Period	$1.81	$1.77

Disclosure_of_Sharebased_Compe

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$0.87	$0.87	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$3.05	$3.05	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding	6,468,799	6,416,043	5,281,945
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	'2 years 5 months 16 days	'4 years 11 months 23 days	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$1.81	$1.77	$1.48
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	6,301,720	4,304,990	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$1.81	$1.69	'

Business_Combination_Segment_A

Business Combination, Segment Allocation (Details)	12 Months Ended		51 Months Ended
	Dec. 28, 2013	Dec. 31, 2012	Dec. 28, 2013	Dec. 01, 2013	Dec. 01, 2013
	USD ($)	USD ($)	USD ($)	USD ($)	EUR (€)
Fair value of assets acquired	'	'	'	$1,797,121	'
Fair value of debt assumed	'	'	'	-1,172,081	-861,551
Deferred income tax liability	'	'	'	-199,131	'
Bargain purchase gain	$425,909	$0	$425,909	'	'

Business_Combination_Separatel

Business Combination, Separately Recognized Transactions (Details) (EUR €)	Dec. 28, 2013
Bank line of credit, bearing interest at 3.25%, repayable June 25, 2014	€ 313,088
Bank line of credit, Interest Rate	3.25%
Bank term loans, bearing interest ranging from 3.1% to 4.55%, repayable between September 2014 and August 2022.	712,881
Bank term loans, Lower Interest Rate	3.10%
Bank term loans, Upper Interest Rate	4.55%
Loan payable on demand bearing interest at 4% per annum	90,897
Loan payable on demand with interest, interest rate	4.00%
Loan payable on demand bearing no interest	68,810
Current and Non-Current portion	1,185,676
Less: current portion	634,486
Non-Current portion	€ 551,190

Schedule_of_Future_Minimum_Lea

Schedule of Future Minimum Lease Payments for Capital Leases (Details) (USD $)	Dec. 28, 2013
Capital Leases, Future Minimum Payments Due, Current	$296,579
Capital Leases, Future Minimum Payments Due in Two Years	209,539
Capital Leases, Future Minimum Payments Due in Three Years	209,539
Capital Leases, Future Minimum Payments Due in Four Years	209,539
Capital Leases, Future Minimum Payments Due in Five Years	209,539
Capital Leases, Future Minimum Payments Due	$1,134,735

Schedule_of_Components_of_Inco

Schedule of Components of Income Tax Expense (Benefit) (Details) (USD $)	12 Months Ended
	Dec. 28, 2013	Dec. 31, 2012
Loss before income taxes	$15,169,933	$9,315,360
Corporate tax rate	30.48%	28.85%
Expected income tax recovery	-4,623,968	-2,654,878
Permanent differences and others	255,649	468,899
Change in valuation allowance	5,155,729	2,324,647
Impact of foreign exchange changes	-564,191	-101,609
Impact of tax rate changes	-223,219	-37,059
Future income tax recovery	$0	$0

Schedule_of_Deferred_Tax_Asset

Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	Dec. 28, 2013	Dec. 31, 2012
Property and equipment and intangible assets	($168,845)	$89,513
Research and development costs	999,811	806,068
Share issue costs	165,590	196,805
Other finance costs	1,883	124,546
Loss carry forwards	10,999,463	5,824,372
Deferred Tax Assets, Gross	11,997,902	7,041,304
Valuation allowance	-12,197,033	-7,041,304
Deferred Tax Assets, Net, Total	($199,131)	$0

Summary_of_Operating_Loss_Carr

Summary of Operating Loss Carryforwards (Details) (USD $)	Dec. 28, 2013	Dec. 31, 2012
Canada [Member]	'	'
Operating Loss Carryforwards	$21,672,697	$17,964,466
Canada [Member] | 2014 [Member]	'	'
Operating Loss Carryforwards	992,010	'
Canada [Member] | 2015 [Member]	'	'
Operating Loss Carryforwards	1,119,758	'
Canada [Member] | 2026 [Member]	'	'
Operating Loss Carryforwards	1,219,361	'
Canada [Member] | 2027 [Member]	'	'
Operating Loss Carryforwards	1,346,174	'
Canada [Member] | 2028 [Member]	'	'
Operating Loss Carryforwards	2,160,578	'
Canada [Member] | 2029 [Member]	'	'
Operating Loss Carryforwards	2,744,383	'
Canada [Member] | 2030 [Member]	'	'
Operating Loss Carryforwards	1,873,136	'
Canada [Member] | 2031 [Member]	'	'
Operating Loss Carryforwards	2,960,048	'
Canada [Member] | 2032 [Member]	'	'
Operating Loss Carryforwards	2,443,098	'
Canada [Member] | 2033 [Member]	'	'
Operating Loss Carryforwards	4,814,151	'
USA [Member]	'	'
Operating Loss Carryforwards	13,507,448	'
USA [Member] | 2014 [Member]	'	'
Operating Loss Carryforwards	0	'
USA [Member] | 2015 [Member]	'	'
Operating Loss Carryforwards	0	'
USA [Member] | 2026 [Member]	'	'
Operating Loss Carryforwards	0	'
USA [Member] | 2027 [Member]	'	'
Operating Loss Carryforwards	0	'
USA [Member] | 2028 [Member]	'	'
Operating Loss Carryforwards	0	'
USA [Member] | 2029 [Member]	'	'
Operating Loss Carryforwards	0	'
USA [Member] | 2030 [Member]	'	'
Operating Loss Carryforwards	75,478	'
USA [Member] | 2031 [Member]	'	'
Operating Loss Carryforwards	594,348	'
USA [Member] | 2032 [Member]	'	'
Operating Loss Carryforwards	3,476,071	'
USA [Member] | 2033 [Member]	'	'
Operating Loss Carryforwards	$9,361,551	'